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 Enzyme catalysis is becoming increasingly important for the synthesis of chiral 
pharmaceuticals and fine chemicals.  However, most enzymes have been optimized by 
nature to perform at specific conditions (i.e., pH, temperature, and medium), generally 
distinct from the desired process conditions.  Advances in molecular biology and protein 
engineering have allowed researchers to tailor enzymes to meet ever-increasing demands. 
 The first goal of this work focused on the development of an amine 
dehydrogenase (AmDH) from a leucine dehydrogenase using site-directed mutagenesis.  
We aimed at reductively aminating a prochiral ketone to a chiral amine by using leucine 
dehydrogenase (LeuDH) as a starting template.  This initial work was divided into two 
stages.  The first focused mutagenesis to a specific residue (K68) that we know is key to 
developing the target functionality.  Subsequently, mutagenesis focused on residues 
known to be in close proximity to a key region of the substrate (M65 and K68).  This 
approach allowed for reduced library size while at the same time increased chances of 
generating alternate substrate specificity.  An NAD+-dependent high throughput assay 
was optimized and will be discussed.   The best variants showed specific activity in 
mU/mg range towards deaminating the target substrate.  
 The second goal of this work was the development of a thermostable glucose 
dehydrogenase (GDH) starting with the wild-type gene from Bacillus subtilis.  Due to the 
high cost of nicotinamide cofactors an efficient regeneration system is vital to the 
development of a process utilizing redox enzymes (including an AmDH).  GDH is able to 
carry out the regeneration of both NADH and NADPH cofactors using glucose as a 
substrate.  We applied the structure-guided consensus method to identify 24 mutations 
that were introduced using overlap extension.  11 of the tested variants had increased 
thermal stability, and when combined a GDH variant with a half-life ~3.5 days at 65oC 
was generated—a ~106 increase in stability when compared to the wild-type. 
 The final goal of this work was the characterization of GDH in homogeneous 
organic-aqueous solvent systems and salt solutions.  Organic media and salts are 
extensively used in organic synthesis to increase substrate stability and solubility as well 
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as enzyme stability.  Engineered GDH variants showed increased stability in all salts and 
organic solvents tested.  Thermal stability had a positive correlation with organic solvent 
and salt stability.  This allowed the demonstration that consensus-based methods can be 
used towards engineering enzyme stability in uncommon media.  This is of significant 
value since protein deactivation in salts and organic solvents is not well understood, 
making a priori design of protein stability in these environments difficult. 
 Lastly, future works for further improving LeuDH and GDH and potential 











 Enzymes are biological macromolecules that catalyze biochemical reactions of 
value to Nature.  After millions of years of evolution, enzymes have been superbly 
optimized.  Most enzymes have evolved exquisite substrate specificity and selectivity 
towards the desired natural reactants and/or products under conditions that promote 
life: aqueous media and mild pH and temperature.  Furthermore, due to the inherent 
low concentrations of substrates in biological systems, some enzymes have evolved to 
work nearly as fast as is physically possible with second-order rate constants that 
approach their rates of collisions with the substrate in solution (~109 s-1M-1) (175). 
 Paradoxically, these evolved traits are what make enzymes both attractive and 
lacking for industrial applications.  Some disadvantages of biocatalysts are: 1) 
enzymes are provided by Nature in only one enantiomeric form (L-amino acids), 2) 
enzymes are prone to inhibition, 3) enzymes tend to be extremely substrate specific 
and selective, 4) enzymes are coupled to their natural cofactors, 5) enzymes require 
narrow operation parameters and 6) enzymes display their highest catalytic activity in 
water (39).   
 Although progress has been achieved toward alleviating these concerns, 
unfortunately, when most enzymes are removed from their natural environment and 
placed in the presence of organic solvents, operating concentrations of reactants 
and/or products, and suboptimal (for the enzyme) but necessary conditions of pH and 
temperature, most natural (wild-type) enzymes will not perform at the required level.  
Due to the narrow operating conditions of the biocatalyst and the fact that biocatalysts 
often represent a significant portion of the process operating costs, once the target 
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synthetic route is known and the biocatalyst defined, process design and optimization 
efforts are focused on the biocatalyst (22, 40).  However, with increasing substrate 
costs, advances in biocatalyst production, and an increase in available, suitable 
biocatalysts, bioprocess design will reach a stage where optimization will center on 
reaction properties and product output rather than on the biocatalyst (22, 104, 122).  
This is critical due to fervent competition, ever more complex molecules, 
environmental pressure and short development times due to patent expiry (22).      
 In a general sense, this work makes three main contributions to further 
develop and adapt biocatalysts for industrial applications.  The first contribution is a 
further understanding of an amino acid dehydrogenase with potential application 
towards the synthesis of chiral amines.  Amines are present ~3 times more frequently 
in synthetic drugs that in natural products (46) with tertiary aliphatic amine 
functionality the most frequent among drug molecules (58).  To date, most synthesis 
of amines is carried out using chemical routes.  Available enzymatic routes rely on 
racemic amines as starting substrates (10, 136), amino acids as amino donors (ω-
transaminases) (146-150), or amine-boranes as reducing agents via chemoenzymatic 
approaches (2, 24, 25).  However, enzymatic synthesis of chiral amines from prochiral 
ketones has not been exploited (65) and to date the best route to chiral amines from 
prochiral ketones relies on ω-transaminases (146).  Unfortunately, ω-transaminases 
suffer from severe product inhibition. 
 In Chapter 2, we describe how a leucine dehydrogenase (LeuDH) is used as a 
starting scaffold for engineering a novel amine dehydrogenase.  Site-saturated 
mutagenesis was done at two key positions identified after reviewing the catalytic 
mechanism and available X-ray structures.  The screening of over 3700 variants 
required the development of a high throughput assay.  This proved to be a challenge 
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since our product is a primary amine and amino acids inherent in the screening 
process (cell lysate), ammonia in the buffer and an aqueous environment rendered 
most techniques ineffective.  Ultimately, an NAD+-dependent fluorescence assay was 
chosen for screening (163).   
 The second contribution of this work focuses on the improvement of 
biocatalyst stability at high temperatures via protein engineering.  In Chapter 3, a 
glucose 1-dehydrogenase (GDH) is engineered using a structure-guided consensus 
method (120, 156, 168).  GDH is an invaluable enzyme used for the recycle of 
nicotinamide cofactors (NAD(P)(H)), coenzymes necessary for enzymatic redox 
reactions.  Due to the high costs of NAD(P)(H), stoichiometric amounts of cofactors 
cannot be used and thus a robust, stable cofactor regeneration system is indispensable 
towards the use of enzymes at a technical scale.   
 Improvement of protein stability by utilizing the consensus sequence (amino 
acid sequence alignments of homologous genes) was first employed by Steipe et al. 
(156) and applied primarily to antibodies (155, 156).  The ease of use and proven 
success rate of consensus-based tools (85, 86, 120, 168) (> 30% success in identifying 
stable mutations—significantly higher than alternative methods such as directed 
molecular evolution) make them an attractive approach to stabilizing enzymes.  
Sequence alignment tools are used to generate a consensus sequence and this 
sequence is then used to identify recurring amino acids at each position.    We then 
used a set of criteria based on the protein structure to sieve through the amino acids 
identified via the consensus sequence.  For GDH, 9.2% of the protein was mutated 
and ~46% of the chosen mutations incurred increased stability.  This approach will be 
most useful for complex enzymes (120) where arbitrary randomization of the gene 
may render the protein inactive, enzymes whose substrates/products are expensive or 
 
 4 
difficult to handle and not amenable to high throughput screening and finally as a 
precursor to the use of  directed molecular evolution where stable scaffolds have been 
shown to improve library results by increasing tolerance to mutagenesis (11, 13).   
 Chapter 4 characterizes four thermostable GDH variants generated via the 
structure-guided consensus concept in homogeneous aqueous-organic media and salt 
solutions.  The four variants selected for characterization had significant differences 
in kinetic stability (as verified by half-lives).  Stability in the presence of high salt 
concentrations and organic solvents would allow enzymes to be employed for 
transformations of compounds not readily soluble at low temperature or in pure 
aqueous systems. 
 In addition to characterizing thermostable GDHs in atypical media, these 
studies allowed us to test the applicability of the structure-guided consensus concept 
towards developing stable enzymes towards other denaturants.  As previously 
observed, a good linear correlation between temperature stability and organic solvent 
stability was observed (31, 113).  Furthermore, thermostable variants demonstrated 
increased salt stability regardless of salt-type and concentration.  This is invaluable to 
protein engineers since deactivation in salt solutions and organic solvents is not well 
understood, rendering a priori design of stable enzymes in this media difficult. 
 Recommendations towards further protein engineering efforts and conclusions 
are summarized in Chapter 5.  In particular, future mutagenesis on leucine 
dehydrogenase towards an amine dehydrogenase should focus on substrate-interacting 
residues and alternative starting protein scaffolds are also considered.  Future efforts 
for further stabilization of glucose 1-dehydrogenase should focus at the protein-
protein interface and an initial attempt via engineered disulfide bonds is discussed.  
Finally, the use of the structure-guided consensus approaches towards stabilization of 





DEVELOPMENT OF A NOVEL DEHYDROGENASE 
 
 2.1 Introduction 
 Nature has customized enzymes to meet specific demands which often are 
incompatible with those desired for industrial processing.  An example of such a 
desired (but lacking) functionality is the transformation of prochiral ketones into 
chiral amines via reductive amination.  Chiral amines are important functional 
elements in a multitude of biologically active pharmaceuticals and their synthesis is of 
importance (46, 58).  For example, Ghose et al. (46) noticed that tertiary aliphatic 
amine is the most frequent functional group in drug molecules while Henkel et al. 
(58) found that amine functionality is found two and three times more frequently in 
synthetic and drug compounds when compared to natural compounds, respectively.    
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 Chemically, amine incorporation is achieved with the hydrogenation of imines 
or enamine derivatives using late transition metal complexes based on chiral P-
ligands, after an initial condensation of the ketone with an appropriate amine (159).  
This approach requires a two step process.  An alternative approach utilizes a 
reducing agent to directly treat the carbonyl and amine substrates.  These 
methodologies are known as indirect (IRA) and direct reductive amination (DRA), 
respectively (Figure 2.1).  
BASF (Germany) developed a lipase-based route to enantiomerically pure 
amines by using ethylmethoxyacetate to stereospecifically acetylate one enantiomer.  
The products (i.e., R-amide and S-amine) can be recovered via distillation at high 
chemical and optical purities (Figure 2.2A) (10, 136).  Although lipase-assisted 
kinetic resolution of racemic amines has been successful in the development of chiral 
amines, the same product can be obtained via reductive transamination of ketones 
(Figure 2.2B) (146-150).  The asymmetric synthesis of chiral amines with ω-
Figure 2.2. A) BASF lipase-based synthesis of enantiomerically pure amines. From 
Balkenhohl 1997 (10). B) Amination of acetophenone by ω-transaminase (149, 150). 
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transaminases has a significant advantage over kinetic resolution in that it does not 
need a racemic amine.  However, the ω-transaminase reaction is very difficult to 
perform due to unfavorable thermodynamic equilibrium as well as severe product 
inhibition, limiting net conversion to ~ 50% (147, 149).  Significant advances have 
been achieved by Turner’s group (University of Edinburgh, UK) using the less 
exploited deracemisation of amines (2, 24, 25) (Figure 2.3).  Utilizing a chemo-
enzymatic approach using ammonia borane and an amine oxidase mutant from 
Aspergillus niger, Alexeeva et al. (2) were able to achieve a one-pot deracemisation 
yielding an amine with > 93% ee and 73% yield.  Subsequent studies demonstrated 
that developed amine oxidase mutants had broad substrate specificity and 
enantioselectivity (25) and were also applied to the deracemisation of cyclic 
secondary amines (24).  Even though amine-boranes posses interesting properties that 
can overcome the disadvantages of other popular hydridic reducing agents (i.e., 
sodium borohydride and sodium cyanoborohydride) such as low stability and high 
toxicity (1), like the BASF lipase-based process this approach requires a source of 
racemic amines or the initial conversion of a keto acid or an aldehyde to an imine.  
Thus, this approach does not allow the direct reductive amination of a prochiral 
ketone to a chiral amine.  
Figure 2.3.  Deracemisation of amines with an amine oxidase in combination with 
ammonia borane.  From Carr 2003(25). 
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To date, Itoh and coworkers (Toyama Prefectural University, Japan) (65) have 
been the only researchers to have reported an NAD+-dependent amine 
dehydrogenase.  This enzyme was found in cell extract from Streptomyces virginiae 
IFO 12827 and the authors detect the reductive amination of keto alcohols, keto acids, 
ketones, and aldehydes.  Unfortunately, the enzyme responsible for this activity in the 
cell extract has not been purified nor further characterized and the DNA and amino 
acid sequence is unknown.   
 In this work we intend to develop an NAD(H)-dependent amine 
dehydrogenase starting from an amino acid dehydrogenase (AADH)—specifically a 
leucine dehydrogenase (LeuDH) from (Geo)Bacillus stearothermophilus strain 10.  
AADHs (EC 1.4.1.X) are part of the oxidoreductase superfamily (21) that catalyze the 
removal of the amino group from an L-amino acid, forming the corresponding keto 
acid with the concomitant reduction of NAD(P)+ (Figure 2.4A).  This LeuDH was 
chosen due to: organism accessibility, known gene sequence, high identity/similarity 
with respect to the available crystallized structure, available kinetic parameters, and 
previous success in overexpression and purification (108-110).  If successful, the 














NAD+ + + H2O NH4
+












developed AmDH will reductively aminate methylisobutylketone (MIBK) to (R)-1,3-
dimethylbutylamine (Figure 2.4B). 
 LeuDH is an octameric enzyme (~320 kDa), first isolated from Bacillus cereus 
(134) and crystallized by Baker et al. from Bacillus sphaericus (8).  The chemical 
mechanism en route from the keto function to the amine group passes through a 
carbinolamine and an imine intermediate before the reductive step to the amine group 
Figure 2.5) (20, 140).  Importantly, the key redox chemistry step, involving NADH 
cofactor, occurs only between the imine and the amine.  However, while the imine of 
an α-keto acid possesses reasonable stability as its carboxyl group is geometrically 
fixed by a lysine (K68) in the enzyme (Figure 2.5), an imine of a ketone is very 
unstable.  Thus, binding and stabilization of the imine intermediate is a key step 
towards the creation of an amine dehydrogenase from LeuDH.   
 A review by Morley et al. (105) compiled results obtained from enzyme 
mutation studies and noticed that to increase catalytic activity (“catalytic 



















































































































promiscuity”), mutations < 10 Å of the active site proved more effective than those on 
residues more distant to it.  As a result, the authors concluded that in these cases, 
random mutagenesis targeting the entire enzyme might not be the best approach to 
find improved variants.  With this in mind—and after careful analysis of the 
mechanism and available crystal structures of amino acid dehydrogenases—it was 
decided to focus on those amino acids that were in the vicinity of the carboxyl being 
replaced.   
2.2 Materials and Methods 
2.2.1 gDNA preparation, gene isolation and overexpression 
 Geobacillus stearothermophilus strain 10 was kindly donated by Assistant 
Professor Bert C. Lampson from East Tennessee State University.  Geobacillus 
stearothermophilus was grown at 60oC in modified Luria Bertani (mLB).  mLB 
contains: 10 g tryptone, 5 g of yeast extract, 5 g of NaCl, 1.25 ml NaOH (10% w/v), 1 
mL nitrilotriacetic acid (1.05 M), 1 mL MgSO4 (0.59 M), 1 mL CaCl2 (0.91 M), 1mL 
FeSO4 (0.04 M) and 995 mL of H2O. Genomic DNA (gDNA) was obtained using 
method B described by Mehling et al. (101).  The gene was isolated from the gDNA 
via polymerase chain reaction (PCR) using primers 5’- 
ATGGAATTGTTCAAATATATGGAAACTTACGATTATGAGC-3’ (forward) and 
5’- TTAAAATGCGAAACTTCTGCTCTTCCATCGTT-3’ (reverse).  The reverse 
primer was chosen to anneal downstream of coding region of the gene due to the rich 
GC content at the 3’ end of the gene.  The gene was later isolated from the larger 
DNA fragment and later cloned into the pPROTet expression vector via the KpnI and 
PstI restriction sites and into the pET17b and pET28a expression vectors via the NdeI, 
HindIII restriction sites.  The pPROTet and pET constructs were tranformed into 
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Escherichia coli (E. coli) DH5αPRO and BL21(DE3), respectively.  DH5αPRO, 
containing the construct (in pPROTet) was grown in LB at 37oC to an OD of 0.5.  At 
this time the culture was induced with 1 mg/mL of autoclaved tetracycline 
(anhydrotetracycline) and incubated overnight at 37oC.  Analogously, BL21(DE3) 
cells containing the construct (in pET28a) were grown in LB at 37oC to an OD of 0.5 
and induced with 0.1 mM IPTG and incubated overnight at 37oC.  Cultures were then 
pelleted via centrifugation. 
2.2.2. Protein purification 
 LeuDHs cloned into pET28a contained a N-terminal 6xHis tag for ease of 
purification.  The cell pellet was resuspended in 50 mM phosphate pH 8.0 with 20 
mM imidazole and 300 mM NaCl.  Cells were then lysed via sonication and cell 
debris removed via centrifugation.  Clarified cell extracts were then purified via 
immobilized-metal affinity chromatography (IMAC) using a Ni-nitrilotriacetic acid 
(NTA) matrix (Qiagen).  Clarified supernatant was loaded onto the resin and washed 
with 50 mM phosphate pH 8.0 with 300 mM NaCl and 50 mM imidazole.  Pure 
protein was eluted with 50 mM phosphate pH 8.0 with 300 mM NaCl and 250 mM 
imidazole.  A representative SDS-PAGE can be seen below (Figure 2.6). 
L = Protein Markers
1 = Lys68Ala - lysate
2 = Lys68Cys - lysate
3 = Lys68Gly - lysate
4 = Lys68Met - lysate
5 = Lys68Ser - lysate
6 = Lys68Thr - lysate
7 = Lys68 - lysate
8 = Lys68Ala - pure
9 = Lys68Cys - pure
10 = Lys68Gly - pure
11 = Lys68Met - pure
12 = Lys68Ser - pure




L     1      2      3     4      5      6     7       L     8  9   10    11   12  13   14
Figure 2.6.  Representative SDS-PAGE of LeuDH wildtype (lane 7 and 14) an 




2.2.3. Spectrophotometric assay 
 Purified samples or cell lysate were tested for activity spectrophotometrically 
via absorbance at 340nm for NAD(H).  For the reductive amination, 1mM 4-methyl-
2-oxopentanoic acid, 200 mM NADH in 1 M NH4Cl/NH4OH pH 9.7 was used.  A 
low concentration (1 mM) of 4-methyl-2-oxopentanoic was required due to its 
absorbance at the analytical wavelength.  For the oxidative deamination, 10 mM L-
leucine, 2 mM NAD+ in 0.1 M glycine at pH 10.0 was used.  For pH profile, pH was 
adjusted with NaOH or HCl prior to assay.  All assays were carried out at 25oC unless 
otherwise specified. 
2.2.4. Mutagenesis and library generation 
 For the first round position Lys68 was saturated using degenerate NNK 
primers: 5’-CGCGGCATGACGTACNNKAACGCGGCCGCCGGCCTTAATTTA-
3’ and 5’- TAAATTAAGGCCGGCGGCCGCGTTMNNGTACGTCATGCCGCG-
3’.  For the second round of mutagenesis Met65 and Lys68 were saturated using NNK 
primers: 5’- CGCCTCGCCCGCGGCNNKACGTACNNKAACGCGGCCGCCGGC-
3’ and 5’-GCCGGCGGCCGCGTTMNNGTACGTMNNGCCGCGGGCGAGGCG -
3’.  Primers were designed using the guidelines provided by Stratagene (Cedar Creek, 
Texas) for its QuikChange® Site-Directed Mutagenesis Kit.  Mutations were 
introduced using the degenerate primers via overlap extension polymerase chain 
reaction (60, 63).   
 For position Lys68, the degenerate gene was cloned into pPROTet, 
transformed into DH5αPRO and random colonies were selected and sent for 
sequencing until all 19 variants were isolated.  Variants were stored for further 
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characterization.  Interesting variants were then cloned into pET28a to insert an N-
terminal 6xHis-tag for protein purification and further characterization. 
 For the second round of site-saturated mutagenesis at position Met65 and 
Lys68, the degenerate gene (randomized cassette) was cloned into pET17b.  
BL21(DE3) cells were transformed and random colonies (20 total) were selected and 
sent for sequencing to test library diversity (Figure 2.7).   
2.2.5. Screening of LeuDH mutants and library 
 For the first round, wild-type LeuDH and 19 variants (site-saturation at 
position Lys68) were screened via gas chromatography (GC).  200 mL cultures were 
grown, pelleted, lysed via sonication and cell lysate used for screening.  2 mL 
reactions were carried out in 4 mL glass vials overnight.  Amination was carried out 
with 8 mM 4-methyl-2-pentanone, 8 mM NADH in 0.7 M NH4Cl/NH4OH pH 8.5.  
For deamination 7 mM 1,3-dimethylbutylamine, 7 mM NAD+ in 0.1 M glycine pH 
10.0.  Reaction mixtures were incubated overnight.  pH was adjusted > 11 prior to 





















AGACGCCTTGCGCCTCGCCCGCGGCA GACGTAC  GAACGCGG CCGCCGGCCTTAATTTAGGCGGGGGCAAGACGGTCATCATCGGCGConsensus (200)
Met65  Lys68
Figure 2.7.  DNA sequence alignment of 20 random colonies to test library diversity. 
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extraction to facilitate isolation of amine.  Extraction was carried out with 1 mL of 
ethyl ether and samples were then loaded to a GC for assay. 
 For the second round, after generating the library, 3752 colonies were picked 
using a Genetix Systems QPix colony picker (Hampshire, UK).  This accounts for a 
97.4% (equation 2.1) probability of complete library screening.  Colonies were 
transferred to 96-well plates containing 250 µL of LB.  Most liquid handling was 
carried out using a MultiDrop® 384 from Themo Electron Corporation (Milford, 
MA).  Plates were grown overnight at 37oC.  Plates were then replicated into 250 µL 
of MagicMediaTM expression medium (Invitrogen, San Francisco, CA).  
MagicMediaTM is an expression medium designed to increase yield of recombinant 
proteins in T7-regulated E. coli systems without the need of adding inducer, 
simplifying the overexpression process (Appendix, Figure A2.1).  Plates were 
incubated and agitated overnight at 37oC.  Cultures were then pelleted via 
centrifugation and store at -80oC until screening.    
ln(1 )
1ln 1
 number of clones required
 probability desired
1














   (2.1) 
 Pelleted cells were resuspended in 50 µL of bacterial protein extraction 
reagent (B-PER-Pierce, Rockford, IL).  B-PER is a cell lysis solution that contains a 
nonionic detergent in 20 mM Tris·HCl pH 7.5, eliminating the need for mechanical 
cell disruption or freeze-thaw cycles.  20 µL of resuspended, lysed cells were 
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transferred to two, distinct black 96-well plates.  These plates were later screened via 
NAD+-dependent fluorescence—one plate was used as background.    
 LeuDH variants were screened using an adaptation of the plate assay 
developed by Tsotsou et al. (163) based on work by Kaplan et al. (73) and Lowry et 
al. (91).  This assay is based on NAD+.  NAD+ is a product during the reductive 
amination of MIBK (Figure 2.4B).  After the reaction, the pH is lowered using HCl 
were the remaining NADH is destroyed.  Then pH is increased and sample incubated 
for 2.5 hours.  During this time the NAD+ is transformed to a fluorescent, stable 
compound (73, 91, 163). 
 To the 20µL cell lysate, 180 µL of reaction mixture was added.  This resulted 
in a total concentration of 8 mM MIBK, 1 mM NADH in 500 mM NH4Cl/NH4OH pH 
9.7.  The reaction was allowed to proceed for at least 2 hours at room temperature 
(~23oC).  pH was then lowered to ~1.0 using 30 µL of 6.0 N HCl.  Plates were 
allowed to sit for at least 15 minutes in the dark.  80 mL of 10.0 N NaOH was then 
added and plates were then incubated for an additional 2.5 hours in the dark.  
Fluorescence was then measured using a Gemini Spectramax Microplate 
Spectrofluorometer (Molecular Devices, Sunnyvale, CA).  Plates were excited at 360 
nm and the emission measured at 455 nm (163).          
2.3 Results and Discussion 
2.3.1. Identification of key residues in LeuDH 
 Due to the lack of a crystal structure of LeuDH with bound substrate (leucine 
or 4-methyl-2-oxopentanoic acid) it was decided to use the crystal structure of 
phenylalanine dehydrogenase from Rhodococcus species (PheDH) (20).  The 
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available structure for LeuDH is from Bacillus spahericus (PDB ID 1LEH) and has an 
amino acid identity of 80% with the LeuDH from (Geo)Bacillus stearothermophilus.  
The available crystal structure for PheDH  (PheDH 1BW9) has bound phenylpyruvate 
(Figure 2.8).  LeuDH from (Geo)Bacillus stearothermophilus and PheDH from 
Rhodococcus species share 34% amino acid identity.  Met63 and Lys66 were 
identified as key residues in PheDH, their counterparts Met65 and Lys68 were 
determined via amino acid sequence alignment and crystal structure comparisons in 
LeuDH.  Lys68 is known to stabilize the α-carboxyl group of the α-keto acid by an 
ionic interaction—a group that will be replaced by a methyl in the target substrate.  
By focusing on the active site—specifically on the amino acids that face the carboxyl 
being replaced to a methyl group on our substrate—we intended to minimize library 
size while at the same time increase our chances of successfully generating the 








Figure 2.8.  Residues ≤ 3.5 Å from the carboxylic acid group of phenylpyruvate of 
phenylalanine dehydrogenase (PDB ID 1BW9).  Residues in parenthesis represent 
the corresponding amino acids in LeuDH. 
 
 17 
form a hydrogen bond with the carbonyl group of the α-keto acids (20, 140).  The 
ketone is expected to bind in the same orientation.      
2.3.2. pH optimization for amination and deamination  of wild-type LeuDH 
 The pH optimum for the amination and deamination of His-tag, wild-type 
LeuDH was determined to be 9.2 and 10.5 for amination and deamination, 
respectively at 25oC (Figure 2.9).  Interestingly the pKa for free ammonia, the amino 
group for leucine and for the ε-amino in the side chain of lysine are 9.2, 9.6 and 10.5, 
respectively.  Thus, the content of free ammonia, the protonated α-amino group of L-
leucine and the protonated ε-amino groups in Lys68 and Lys80 are critical for the 
substrate stabilization and catalysis.  Vanhooke et al. (20) carried out pH studies on L-
phenylalanine dehydrogenase from Rhodococcus and determined that in the direction 
of L-phenylalanine synthesis two enzymic groups with pKas of 9.4 and 8.1 are critical 
for catalysis.  The authors assigned the higher pKa value to Lys78 (Lys80 in LeuDH), 
a residue known to form a strong hydrogen bond (when protonated) with the carbonyl 






























oxygen of the α-keto acid.  Similarly, Sekimoto and coworkers identified Lys68 (138) 
and Lys80 (140) via pH studies and determine that both need to be protonated during 
binding and catalysis (Figure 2.9). 
  
2.3.3. Characterization of LeuDH variants: site-saturation at Lys68 
 After acquiring all 19 variants of LeuDH, they were screened for amination 
and deamination activity via GC.  Of the tested variants none were detected to 
aminate MIBK, while six (i.e., Lys68Ala, Cys, Gly, Met, Ser, and Thr) were detected 
to deaminate 1,3-dimethylbutylamine.  These variants were then cloned into an N-
terminal His-tag containing vector for purification and further characterization.  Once 




purified enzyme was obtained, variants were characterized to determine their ability 
to aminate and deaminate various substrates (Table 2.1).  Of the six variants 
Lys68Met and Lys68Ser seem to be the most promising since deamination of 1,3-
dimethylbutylamine was detected in mU/mg range (i.e., 8.3 and 3.4 mU/mg, 
respectively). 
2.3.4. Development of a high throughput assay 
 In an attempt to further improve the activity of LeuDH toward amination we 
decided to randomize both Met65 and Lys68 simultaneously.  The randomization of 
these two positions around the area of interest allows for potential synergistic 
conformational effects arising from unpredictable interactions that cannot be observed 
by single-site mutagenesis (129) (Figure 2.10).  To properly screen this library more 
than 3000 variants need to be screened.  
    En route to finding an appropriate screening approach many challenges were 
encountered.  The biggest challenge was finding a screening method selective toward 
primary amines but not amino acids.  Benzofurazan fluorescent compounds, such as 
4-chloro-7-nitrobenz-2-oxa-1,3-diazole (NBD-Cl) and 4-fluoro-7-nitrobenz-2-oxa-
A) B)
Figure 2.10.  A) Orientation of side chains based on secondary structure 
(129).  B) Location of Met65 and Lys68 (shown in green) 
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1,3-diazole (NBD-F) have been previously used for high throughput experiments (57).  
NBD-F has the advantage of being ~500 times reactive than NBD-Cl (103), but it is 
~800 times more expensive (57).  Unfortunately, in an aqueous environment, NBD-F 
hydrolyzes to form 4-hydroxy-7-nitrobenzo-2-oxa-1,3-diazole, a fluorescent product 
(103) and ammonia also reacts with NBD-Cl/F rendering this technique inappropriate 
for LeuDH. 
 Ultimately, an NAD(P)(H) fluorescent assay was chosen for screening.  This 
assay was reported by Tsotsou et al. (163) based on initial work by Lowry et al. (91) 
and Kaplan et al. (73).  In this work, produced NAD+ was converted to a fluorescent 
product under an alkaline environment.  Sensitivities in the 0.01 µM for the NADP+ 
fluorophore have been reported (89).  The effect of B-PER, cell lysate, volume of acid 
and base, and buffer was tested to minimize background, improve ease of handling 
and test sensitivity (see materials and methods for final conditions used).  Our first 
goal was to be able to achieve reaction, pH changes and measurements in a single 
plate.  Previous work carried out reaction and pH changes in distinct microtiter plates 
(total of three) (163).  With this in mind, B-PER and cell lysate (from BL21(DE3)) 
were tested to quantify potential effects on background (Figure 2.11).  10 µL of B-
PER with (~862 µg/mL of BL21(DE3) cell lysate) and without cell lysate  was tested.  
B-PER with cell lysate resulted in a slightly higher background, this is observed in a 
higher intercept (increased background) and a reduction in the slope values (reduction 
in sensitivity).  pH is also known to influence stability of nicotinamide cofactors (69, 
90, 164, 177).  Qualitatively, NAD(P)H is more stable in acidic conditions while 
NAD(P)+ is more stable in alkaline solutions (90, 177).  In this experiment we aimed 
to elucidate the required HCl and NaOH to destroy NADH and produce the alkaline 
fluorescent NAD+ product.  To do this, different volumes of 6.0 N HCl and 10N 
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NaOH were added and fluorescence measured (Figure 2.12).  It is evident that at least 
10µL of 6.0 N HCl is necessary for complete destruction of NADH.  This is observed 
with a sharp reduction in fluorescence at volumes greater than 10µL of 6.0 N HCl.  A 
leveling in fluorescence is observed for all volumes (concentrations) of NaOH with 
values ranging from 91 to 302 relative fluorescent units (RFU).  For the final assay 30 
µL of 6.0 N HCl and 80 µL of 10.0 N NaOH were used.  A higher concentration of 10 
N NaOH was used since it has been observed by Kaplan et al. (73)  that competing, 
unwanted reactions can be minimized at higher concentrations of NaOH.  Stability of 
NAD(H) was also studied in 0.5 M NH4Cl/NH4OH pH 9.7 (Figure 2.13).  It is evident 
that incubation overnight in 0.5 M NH4Cl/NH4OH pH 9.7 causes an increase in 
background and a decrease in sensitivity.  No significant changes were observed 
between 1 hour and 4 hour incubation.  For the final fluorescence assay, samples were 
incubated for at least 2 hours.   





























Cell Lystate in B-PER
B-PER
Linear (Cell Lystate in B-PER)
Linear (B-PER)








































































































BL21 Cell Lysate in B-PER overnight
BL21 Cell Lysate in B-PER 4hr






















Figure 2.13.  Effects of incubation time in reaction buffer on fluorescence assay. 
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 Finally, to test the sensitivity of the assay, different protein loadings of 6xHis-
tag, wild-type LeuDH was used in the reductive amination of its natural substrate (4-
methyl-2-oxopentanoic acid) (Figure 2.14).  This will allow estimation of the specific 
activity necessary of the novel enzyme for detection.  The enzyme stock used had a 
specific activity of 5.75 U/mg for pure protein and of 1.16 U/mg for cell lysate (high 
activity is not necessary since we are interested in testing sensitivity).  Being 
conservative and taking 10 ng of pure protein as our detection limit (RFU for 10ng is 
922 while for 1ng is 270—this corresponds to ~3.4 times greater than the lowest point 
recorded) the assay can detect an enzyme than can produce 5.75x10-11 moles of 
NADH/min.  In our screening process the average protein loading was ~18 µg of 
protein per well.  Assuming that 35% of the loaded lysate protein is the LeuDH 
variant of interest the assay should be able to detect an enzyme with a specific activity 
Figure 2.14.  Sensitivity of fluorescence assay based on protein loading. 
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of ~ 9.1 mU/mg.  A schematic representation of the fluorsecence assay can be seen 
below (Figure 2.15).      
 
2.3.5. Screening of Met65NNK, Lys68NNK library 
 Equipped with a high-throughput NAD+ fluorescence assay (see above) (163), 































































































































































































































































































































































































































































































































































































































































































































































Figure 2.15.  Schematic representation of fluorescence NAD+ assay. 
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colony picker and some partial empty plates, a total of 43 96-well plates were used.  
Plates were excited at 360 nm and fluorescence was measured at 455 nm (Figure 2.16, 
to see all plots see Appendix, Figure A2.2-A2.5).  The radial axis represents RFU 
(with background subtracted) while the radial grid represents one well of the 96 in a 
plate.  For each well a blank was measured (without substrate) and subtracted.  The 
library mean fluorescence (in RFU) was 858.79 ± 7.7 (± values represent a 95% 
confidence interval unless otherwise stated) while for the background the mean 
fluorescence was 865.09 ± 7.75 (Figure 2.17).  Statistically there is no difference 
between the reading with and without MIBK.  When each background is subtracted 
from its corresponding variant the mean fluorescence is -6.303 ± 3.64.  For 











































































































Figure 2.16.  Plot 1, screening of LeuDH variants. 
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thoroughness, the top 20 variants based on fluorescence were sent for sequencing 
(Table 2.2).  These variants had a mean RFU of 1574.5 ± 158.5 with a background of 
936.15 ± 123.  The mean fluorescence (minus background) was 638.36 ± 53 (Figure 
2.17).  For complete statistical analysis of library see Appendix (Figure A2.5-A2.10).  
For the top 6 clones, it is evident that other than Lys68Glu (clone 1) and Met65Asn 
(clone 3), hydrophobic amino acids are prevalent (Table 2.2).    
2.3.6. Screening of promising LeuDH variants via GC 
 The top 20 variants were then tested via GC to verify product formation.  The 
variants were tested both for amination and deamination of MIBK and 1,3-
dimethylbutylamine.  For amination, 8 mM MIBK, 1 mM NADH, 500 mM 
NH4Cl/NH4OH pH 9.7, 8.8 mM D-glucose and 0.5 mg/mL of GDH-103 
(Biocatalytics now Codexis, Redwood City, CA) was used.  The addition of a 
recycling system (GDH-103) will allow us to overcome equilibrium limitations.  For 













Avg (+MIBK) Avg Bkgd (-MIBK) Avg - Avg Bkgd Avg Top 20 Avg Bkgd of Top 20
Variants





Figure 2.17.  Summary of LeuDH variants.  Avg = average, Bkgd = background. 
 
 27 
was used.  2 mL reactions were prepared with 100 µL of clarified cell extract.  
Reactions were incubated overnight at room temperature.  pH was then adjusted to > 
11 and extracted with 1 mL of dichloromethane (CH2Cl2).  Samples were then loaded 
to the GC.  Unfortunately, no amination or deamination was detected. 
 Since the Km of these substrates is unknown, experiments were repeated under 
the same conditions but with saturated MIBK (solubility of MIBK in water at 25oC is 
170 mM (154)) and saturated 1,3-dimethylbutylamine.  Again, no amination or 
deamination was detected.  
 
2.4 Conclusions 
 In summary, we have carried out site-saturated mutagenesis at position Lys68.  
Six variants: 1) Lys68Ala, 2) Lys68Cys, 3) Lys68Gly, 4) Lys68Met, 5) Lys68Ser and 
6) Lys68Thr seem to carry out the oxidative deamination of 1,3-dimethylbutylamine.  
Table 2.2.  Sequences and fluorescence (RFU) of the top 20 LeuDH variants. 
Clone Position 65 Position 68 RFU
1 Leu Glu 935.296
2 Met Leu 792.708
3 Asn Phe 778.014
4 Ala Met 759.867
5 Met Leu 743.039
6 Phe Trp 689.327
7 Leu Cys 674.582
8 Met Arg 642.346
9 Thr Glu 629.916
10 Met Ser 619.663
11 Met Lys 583.849
12 578.416
13 Tyr Cys 574.011
14 Tyr Glu 555.483
15 Lys Trp 552.431
16 Leu Stop 542.891
17 531.83
18 Phe Glu 528.529
19 Ile Lys 528.075





These six variants were later cloned into a vector with an N-terminal 6xHis-tag for 
purification.  Using UV-absorbance we were able to estimate specific activities and 
Lys68Met was the best variant at this stage.  Lys68Met had a specific activity of 8 
mU/mg for the oxidative deamination of 1,3-dimethylbutylamine and 0.2 mU/mg for 
the reductive amination of MIBK.  These results have not conclusively been 
corroborated via GC.  We believe the low activity of the enzymes in addition to 
potential product loss during extraction leads to no detection of product via 
chromatography. 
 In an attempt to further increase the amine dehydrogenase activity of LeuDH, 
site-saturated mutagenesis was carried out at Met65 and Lys68.  3752 variants were 
screened via an NAD+ fluorescence assay.  The top 6 variants were: 1) Met65Leu 
Lys68Glu, 2) Met65 Lys68Leu, 3) Met65Asn Lys68Phe, 4) Met65Ala Lys68Met, 5) 
Met65 Lys68Leu, and 6) Met65Phe Lys68Trp.  Again, methionine is prevalent at 
position 65 and other than glutamate, hydrophobic residues are prevalent at position 
68.  As before, we believe low activity does not allow for the conclusive 
corroboration of product via GC or other analytical tools such as NMR.  Amine and 
ketone were not detected via GC above baseline at concentrations < 5 mM and < 0.5 
mM, respectively.  
 The enzymatic reduction of prochiral ketones to chiral amines still remains a 
desired chemistry in the chemist’s tool kit.  To demonstrate that amino acid 
dehydrogenases have the potential to reductively aminate a prochiral ketone would be 
a significant accomplishment.  Amino acid dehydrogenases have been shown to 
reductively aminate via the same mechanism (9, 20, 140).  This would suggest that if 
an amino acid dehydrogenase is proven to reductively aminate, there is prospect of 
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converting other enzymes of this family into amine dehydrogenases.  This would be a 
great accomplishment since this family of enzyme accepts a wide range of amino acid 
side chains  and will allow chemists to reductively aminate a wide array of 
nonproteogenic substrates.  









 In an effort to produce increasingly complex chemical products, a number of 
research efforts focus on the development of proteins with novel functionality and 
improved activity, selectivity, and stability (15, 17, 43, 74, 112, 122, 128).  Many of 
these products are required to be enantiomerically pure for biological activity and 
often require processing at nonnative conditions of pH, solvent, and temperature.  As 
the proteins have not been optimized for such nonnative conditions during evolution, 
protein stability often is insufficient.  A number of strategies have been employed to 
apply protein engineering to modify protein structural features to improve their 
stability.  These include improved core packing, (41, 79) turn optimization, (153) 
increased rigidity by Xaa to Proline or Gly to Xaa substitutions, (44, 100) optimizing 
surface charges, (157, 179) introduction of disulfide bridges,(96) and improved 
hydrophobic interactions (82).   
 Protein engineering methods can generally be classified into one of three 
categories: rational, (37) combinatorial, (38) and data-driven protein design (14, 26, 
119).  Combinatorial protein design, often called directed molecular evolution, 
involves the iteration of diversity generation with subsequent selection or screening to 
identify improved variants.  The advantage of this approach lies in that little 
knowledge of the protein is required for its application.  However, its success relies on 
the availability of an effective selection or screening tool to sieve through the large 
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number of variants that are produced.  In contrast, rational design requires extensive 
knowledge of protein structure and function to identify specific mutations to make, 
and thus generates a manageable number of variants.  Lastly, data-driven protein 
design utilizes available sequences, structures, mechanisms as well as activity, 
selectivity, and stability data to identify potential amino acids or domains to target for 
mutation.  In data-driven protein design, methods based on sequence alignments are 
promising; these methods are traditionally applied to homologous protein families to 
allow a reduced number of candidates.   
  Steipe et al. (156) were the first to demonstrate the consensus concept to create 
thermostable immunoglobulin domains.  This concept determines the most prevalent 
amino acid at a given position of an alignment of homologous proteins.  The resulting 
sequence of most prevalent amino acids is termed the consensus sequence.  
Consensus stabilization of proteins is based on the notion that the frequency of 
sequence elements correlate with stability contribution (156).  This fundamental 
assumption was corroborated by analyzing a library of thermostable cytochrome 
P450s generated via a consensus approach (88).  Lehmann et al. (85-87) and Amin et 
al. (3) later applied the consensus approach to generate a stable fungal phytase and β-
lactamase, respectively.  Watanabe et al. (171) utilized a phylogenetic approach to 
identify ancestral amino acids that ultimately conferred thermal stability onto a 3-
isopropylmalate dehydrogenase.  Binz et al. (12) used a consensus approach to 
develop a conserved scaffold (i.e., residues important for maintaining repeat structure) 
in which potential interacting amino acids where randomized en route to improving 
interactions between repeating units of the ankyrin protein.  This resulted in increase 
expression, solubility and stability of the ankyrin repeat protein.  DiTursi et al. (35) 
used Bayesian sequence-based algorithms on serine protease sequences to identify a 
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stabilizing motif in subtilisin E, improving its melting temperature by 13oC.  In cases 
of low levels of sequence identity and/or few available amino acid sequences, 
however, the consensus residue of a specific position cannot be found easily or not at 
all.  We therefore developed the structure-guided consensus approach—which utilizes 
structural information (in addition to other criteria; see below) to reduce the number 
of residues in a given protein to be mutated and checked for stabilization—and 
demonstrated thermostabilization on penicillin G acylase  (PGA) in 47% (10 of 21) of 
investigated single variants (120).  To this end we had only 8 sequences, ranging from 
32.5 to 87.7% and 28.6-87.6% amino acid identity for the α- and β- chains, 
respectively.  Moreover, PGA is a large, heterodimeric entity with a complicated 
maturation process to the active protein (23 and 63 kDa in α- and β-subunit, 
respectively) and so is difficult to access through rational or combinatorial design.  
Here we extend the structure-guided consensus approach to an important, 
homotetrameric biocatalyst with cofactor-dependent catalysis: glucose 
dehydrogenase. 
 Glucose dehydrogenase (GDH; E.C. 1.1.1.47) catalyzes the regeneration of 
either NADH or NADPH from the oxidized precursors NAD+ or NADP+ with 
concomitant oxidation of inexpensive and readily available glucose (61) (Figure 3.1); 
its high specific activity, up to 550 U/mg, (116) towards both NAD+ or NADP+ by far 
surpasses other approaches (174, 183).  Because of the prohibitively high prices of 
nicotinamide cofactors, in combination with the requirement of cost-effective 
industrial processes, a robust cofactor regeneration system is a necessity for the 
production of enantiomerically pure compounds from prochiral precursors.  Prior 
attempts to develop thermostable cofactor-recycling enzymes (6, 68, 93, 107) have 




Figure 3.1. Cofactor reduction by glucose 1-dehydrogenase.  
3.2. Materials and Methods 
3.2.1 gDNA preparation and gene isolation 
 Bacillus subtilis strain 167 was obtained from the Bacillus Genetic Stock 
Center (BGSC No. 1A1) as spore dots.  Spores were plated and then grown in LB at 
37oC.  Genomic DNA (gDNA) was obtained using method B described by Mehling et 
al. (101).  GDH was isolated from gDNA using the primers, 5’-
ATGTATCCGGATTTAAAAGGAAAAGTCGTCGC-3’ and 5’-
TTAACCGCGGCCTGCCTGGAATGAAGGATATTG-3’.   
3.2.2. Site-directed mutagenesis, cloning and overexpression 
 Mutations were introduced using primers via overlap extension (60, 63) and 
then sequenced for confirmation.  Overlap extension was favored due to the ability to 
successively follow progress and its robustness.  Primers were designed using the 
guidelines provided by Stratagene (Cedar Creek, Texas) for its QuikChange® Site-
Directed Mutagenesis Kit.  Variants were cloned into pET28a (Novagen, Madison, 
WI) vector carrying an N-terminal His-tag via the NdeI and HindIII sites and the 
assembled vector was transformed into E. coli BL21(DE3) (Invitrogen, Carlsbad, 
California).  Overnight cultures from a single colony containing the plasmid were 
used to inoculate 300 mL cultures.  Fermentations were grown to an OD600 of 0.3-0.5 
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at 37oC, induced with 0.1 mM IPTG, and incubated for 16 h.  Cultures were then 
pelleted by centrifugation.   
3.2.3. Protein purification 
 Pelleted cells were resuspended in 50mM phosphate pH 8.0 with 300 mM 
NaCl and 20 mM imidazole.  Cells were lyzed via sonication.  Clarified cell extracts 
were purified by immobilized-metal affinity chromatography (IMAC) using a Ni-
NTA resin (Qiagen).  Clarified cell extracts were loaded onto the resin and washed 
with 50 mM phosphate pH 8.0 with 300 mM NaCl and 50 mM imidazole.  Pure 
protein was eluted with 50 mM phosphate pH 8.0 with 300 mM NaCl and 250 mM 
imidazole.  A representative SDS-PAGE image can be seen below (Figure 3.2). 
 
Figure 3.2. SDS-PAGE-Purified Samples.  Lane L: Protein markers (i.e., 116, 66.2, 
45.0, 35.0, 25, 18.4, and 14.4 kDa), Lane 1: Eluted HisGDH Q252L, Lane 2: Clarified 
cell extract Q252L, Lane 3: Eluted HisGDH K107E, Lane 4: Clarified cell extract 
K107E, Lane 5: Eluted HisGDH P45A, Lane 6: Clarified cell extract P45A, Lane 7: 
Eluted HisGDH wild-type, Lane 8: Clarified cell extract. 
 
3.2.4. Spectrophotometric assay and circular dichroism 
 Purified, single variants were incubated in elution buffer (50 mM phosphate 
pH 8.0, 300 mM NaCl and 250 mM imidazole) at 25oC or 65oC and residual activity 
35kDa
25kDa
L      1      2      3      4     5      6     7      8
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monitored spectrophotometrically at 25oC by NADH absorbance at 340 nm.  
Measurements were made in a Beckmann-Coulter DU®800 (Fullerton, CA) 
spectrophotometer.  Triplicate assays were carried out in 50 mM phosphate (NaH2PO4 
pH 8.0) with 1 mM NAD+ and 100 mM D-glucose.  CD ellipticity at 222 nm was 
measured using a Jasco J-810 (Easton, MD) with a Peltier-controlled cell holder.  
Purified samples were dialyzed against 50mM phosphate pH 8.0 with 300 mM NaCl 
to remove imidazole prior to measuring apparent melting temperature (Tm).   CD was 
carried out at a protein concentration between 100-200 µg/mL in a 1 mm path length 
quartz cuvette. 
3.2.5. Calculating Apparent Melting Temperature 
 Using CD it is possible to monitor effects on secondary structure (e.g., at 222 
nm we observe changes in α-helix).  A representative protein melting plot represented 
in ellipticity (in mdeg) at 222 nm against temperature can be seen below (Figure 3.3).  
Data was nonlinearly fit to a simple sigmoidal model (equation 3.1) using SigmaPlot 
8.0.  From this data the Tm was calculated as a fitted parameter to equation 3.1.  
Temperature (C)
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3.3. Results and Discussion 
3.3.1 Identification of substitutions in GDH from Bacillus subtillis 
In generating a temperature-stable cofactor regenerating system, we decided to 
use the highly active but thermally labile glucose dehydrogenase (GDH) from 
Bacillus subtilis strain 168 (B. subtilis) as a starting template due to its high activity 
towards NAD+ and NADP+ (127).  In addition, a homolog was previously stabilized 
by directed molecular evolution by screening 40,000 colonies, (6, 93, 107) allowing 
us to compare our results directly.  There are over 200 available homologous 
sequences for GDH (we counted 244).  Sequences were narrowed down by 
considering only active glucose-1-dehydrogenases and putative or probable genes, 
also sequences were selected as to represent the main branches of the phylogenetic 
tree to reduce bias toward highly similar sequences (see Appendix, Figure A3.1).  
This resulted in 12 additional GDHs. 
 The sequences we picked ranged in amino acid identity from 24.8 to 61.1% 
with respect to the wild-type—a significantly lower and more expansive range than 
previous applications of the consensus concept by other groups, but still assuring 
essentially the same three-dimensional structure for all chosen sequences, as GDH 
belongs to the structurally well-conserved family of short-chain dehydrogenases (70).  
To pick substitutions, the alignment was carried out using PRALINE, (59, 151, 152) a 
multiple sequence alignment tool that generates pre-alignment profiles for each 
sequence in a given set using database searching.  The alignment was carried out with 
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use of the default settings, in which neither the structural-expanded search nor pdb 
files were utilized for the alignment.  These profiles replace the single-sequence input 
and are progressively aligned, allowing the incorporation of extensive position-
specific information from homology-profiles (for output, see Appendix, PRALINE 
alignment and consensus sequence with corresponding Table A3.1).  From this 
alignment, 31 of the 261 positions were distinct and at least 50% frequent in the 
consensus sequence.  The 50% consensus cut-off can be varied depending on the 
screening capacity and the stringency of other criteria.  The candidates were further 
reduced by applying the following criteria: 1) the substitution had to be more than 6 Å 
from the cofactor binding site, to reduce effect of mutagenesis on activity, 2) amino 
acid secondary structure propensity was considered (for example, if the mutation was 
found in a helix, a helix-stabilizer was not changed to a helix-destabilizer), and 3) 
amino acids involved in existing direct hydrogen-bonds or salt-bridges were left 
unchanged.  For this, a homology model based on the crystal structure from B. 
megaterium IWG3 (180) (84% identical to GDH from B. subtilis) was used.  These 
criteria should be modified based on available knowledge and data on a specific 
protein.  For example, quaternary structure integrity is critical for activity and stability 
of GDH (7, 61) as well as many alcohol dehydrogenases (80).  Thus, strengthening 
subunit-subunit interactions is critical for stabilization.  As we wanted to evaluate the 
importance of the interface in stabilization of GDH, we did not include location at the 
subunit interface as a criterion for inclusion in or exclusion from the list of targeted 
amino acid substitutions (see Appendix Figure S3.2).  Application of criteria 1) to 3) 
reduced the number of targeted amino acid substitutions from 31 to 24 (9% of the 
total protein), of which seven are located at the subunit interface.  Glutamate at 
position 170 was mutated into both arginine and lysine because no residue occurred 
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with more than 50% frequency but more than 60% of the residues were R or K with 
more than 90% being charged (i.e., five arginines, four lysines, three glutamic acids, 
and one valine). 
 In this approach, the most important inputs are the amino acid sequences 
selected and the consensus cut-off percentage, which, when tuned by the 
experimentalist, significantly impacts the number of variants to be studied.  We 
decided not to disrupt any preexisting stabilizing interactions based on the homology 
model and an available crystal structure (180).  In addition, amino acid propensities 
toward different secondary structures have been extensively studied and thus are 
considered as a reasonable criterion for reducing potential candidates (94, 145).  
Finally, Morley and Kazlauskas, (105) scrutinized the literature to study the relation 
between mutation distance from the active site and its effect on enantioselectivity, 
selectivity, activity, and thermal stability.  For the last of these, the authors do not 
observe beneficial mutations closer than 8 Å from the active site, though in all cases 
mutations < 5 Å were rarely observed.  Thus, our criterion for substitutions to be > 6 
Å from the active site is reasonable, if rather conservative.  
3.3.2 Single variants 
 GDH variants were generated by overlap extension and cloned into pET28a, in 
frame with the N-terminal His-tag.  Variants were expressed in Escherichia coli 
(BL21DE3) and purified using immobilized metal affinity chromatography (IMAC).  
Purified, single variants were incubated in elution buffer at 25oC or 65oC and residual 
activity monitored spectrophotometrically at 25oC by the decrease in NADH 
absorbance at 340 nm.  Specific activities were measured immediately after 
purification to minimize deactivation.  Half-lives were determined from residual 
activity with first-order deactivation kinetics (Figure 3.4).  
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 When we compare the results for single mutants of all 24 of the selected 
residues, 11 had higher thermal stability compared to the wildtype, seven had a lower 




Figure 3.4.  Half-lives and specific activity for HisGDHs.  A)25oC, B)65oC.  Error 
bars for half-lives represent 95% confidence intervals.  Error bars for specific activity 
represent standard deviations.  The most stable variant in the top is the least stable in 
the bottom one. 
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to a 46% success rate, comparable with our previous application of this technique in 
penicillin G acylase (120).  In contrast, a combined 40,000 variants generated via 
chemical mutagenesis (93) and family shuffling (6) were previously screened to 
identify E170K and Q252L.  This is typical of directed molecular evolution; Johannes 
et al. screened 19,000 variants created by error-prone PCR and identified 12 amino 
acids that increased the thermal stability of phosphite dehydrogenase (PTDH) (68). 
 If we had limited our search to amino acids at the subunit-subunit interface, 
we would have had to characterize seven variants and would have found six with 
higher thermostability (G114E, F155Y, E170(K or R), V227A, W230F, and Q252L) 
and one less stable one (A246V).  This finding is equivalent to a 86% success rate, 
and the successful set included the best variants: F155Y, E170(K orR) and Q252L 
(see Appendix, Figure A3.2).   
 All active variants had essentially unchanged levels of expression.  The three 
inactive variants—Q31G, K204E and K234D—came as a consequence of aggregation 
as verified by SDS-page (Figure 3.5).  All three substitutions were present at the 
protein surface, and the instability might have been an effect of decreased rigidity for 
Q31G and unfavorable charge distributions for K204E and K234D.  K204E is in close 
range of D202 and D208, while K234D is flanked by D4, E223, and E235.  Although 
interaction of charged residues is difficult to predict, it has been shown to be 
important for protein stability (157, 179) and could thus be considered in the future as 
a criterion to minimize inactive variants.   
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 On reviewing the selection criteria it is evident that, although the consensus 
sequence is effective in predicting stabilizing residues, the stability of the variant or 
its success are not directly related to the frequency of a particular amino acid.  The 24 
amino acids had a frequency ranging from ~50 to ~ 80%, but the more frequent ones 
did not seem to confer more stability.  For example, the three inactive variants Q31G, 
K204E, and K234D had a consensuses of 80, 70 and 60% respectively.  In addition, 
the stabilizing mutations that were ultimately chosen for subsequent combination and 
characterization (see below)—P45A, N46E, F155Y, E170(K or R), V227A, W230F, 
and Q252L—had a consensus ranging between 50-70% (i.e., 60, 50, 50, 60, 70, 50, 
and 60%, respectively).  From this it is evident that we would not have benefited by 




L      1        2       3       4        5       6 
Figure 3.5. SDS-Page 1-Aggregated Samples.  Lane L: Protein markers (i.e., 150, 100, 75, 50, 
37, 25, 20, 15, and 10 kDa), Lane 1: Clarified cell extract HisGDH Q31G, Lane 2: Clarified cell 
extract HisGDH K204E, Lane 3: Clarified cell extract HisGDH K234D, Lane 4: Solubilized cell 
debris HisGDH Q31G, Lane 5: Solubilized cell debris HisGDH K204E, Lane 6: Solubilized cell 




3.3.3. Combining single mutations 
 Only single variants that resulted in at least a 50% increase in thermal stability 
relative to the B. subtilis wild-type (i.e., P45A, N46E, F155Y, E170(K or R), V227A, 
W230F, and Q252L) were combined and further analyzed.  However, the effect of 
two mutations—Q252L and E170(K or R)—dominate the effect of the other 
individual substitutions.  When substitutions are combined, we can gather the 
following order in increasing stability: P45A/V227A < P45A/F155Y/V227A < 
P45A/N46E/F155Y/V227A/W230F < Q252L < E170(K or R) < E170(K or 
R)/Q252L.  As can be observed, some mutations, when combined, increase the half-
life (i.e., P45A, F155Y, V227A and W230F) while others do not (i.e., N46E).  As in 
the case of single variants, the amino acid changes Q252L and E170(K or R) in 
combined mutations of B. subtilis GDH contribute significantly to stabilization while 
the others (i.e., P45A, N46E, F155Y, V227A, W230F) make minor contributions, 
resulting in a plateau of stabilization for Q252L/E170(K or R) variants of GDH that 
does not seem to be overcome with additional mutations.  The role of Q252L and 
E170(K or R) for GDH stabilization is in agreement with the findings of Baik et al.(6, 
7)  who discovered the importance of residues Q252L and E170K in the stability of 
GDH.  Assisted by crystal structures from the wild-type and mutant GDHs from 
Bacillus megaterium IWG3, Baik et al. determined that a cooperative effect between 
Q252L and E170K stabilizes the tetramer structure by strengthening the hydrophobic 
interactions within the interface(7)— significant, since GDH has been demonstrated 
to be an obligate tetramer.  We surmise E170R has a similar structural effect on GDH.  
The half-life of the best variant was ~ 3.5 days (inactivation constant ~ 2.2x10-6 s-1) at 
5oC with specific activities ranging from 100-145 U/mg at 25oC.  The variants had a 
higher thermal stability and specific activity when compared to GDH-103, a 
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commercially available (Biocatalytics now Codexis, Redwood City, CA) thermostable 
GDH.  The superior specific activity is a result of better purity achieved through 
IMAC chromatography—corroborated with SDS-page (Figure 3.6)—and possibly of 
the added His-tag of our enzyme.  Specific activity is the clear advantage of GDH 
when compared to commercially available NAD+ and NADP+ formate 
dehydrogenases (FDH; 5-20 U/mg at 25oC-30oC) and phosphite dehydrogenase (5 
U/mg at 25oC) since inactivation constants as low as 9.7x10-8 s-1 at 55oC and 1.37x10-
6s-1 at 45oC, respectively, have been reported for FDH and PTDH (68, 162).+ 
Figure 3.6.  SDS-Page GDH 103 (Biocatalytics now Codexis, Redwood City, CA). 
3.3.4. Incorporation of F155Y, E170K, and Q252L into homologues 
 To test the broad applicability of the structure-guided consensus concept 
across homologs, the three most significant mutations (F155Y, E170K, and Q252L) 
were chosen and appropriate amino acid changes were introduced into two 
homologous GDH scaffolds.  The two selected candidates (Bacillus thuringiensis and 
Bacillus licheniformis) were in the same branch as B. subtilis and share 81.7% and 
67.2% amino acid identity, respectively. 
 HisGDH from B. thuringiensis was as active (specific activity: 93 U/mg vs. 87 
U/mg at 25oC and pH 8.0) and deactivated much more slowly than the B. subtilis 
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wildtype but slightly more rapidly than its improved variants (Table 3.1).  
Interestingly, the kinetic stability (that is the half-life) of the most stable B. 
thuringiensis variant (E170K/L252) is only slightly less than the equivalent B. subtilis 
variant (E170K/Q252L) at the same temperature and pH value (65oC, pH 8.0).  In 
contrast, HisGDH from B. licheniformis was hardly active (50mU/mg at 25oC, pH 
8.0) and so we additionally measured the thermodynamic stabilities of all variants 
through their apparent melting temperatures (Tm) by circular dichroism (CD) at 222 
nm (Table 3.1).  For comparison, half-lives of promising candidates were determined. 
 
Table 3.1.  Half-lives and apparent melting temperatures (Tm) as measured by CD. 
 We have demonstrated that in fact the mutations F155Y, E170K, and Q252L 
confer increased stability on homologs (except in one situation).  F155Y stabilizes all 
three homologs, albeit slightly (1.2 - 4.5 K).  The mutation E170K markedly stabilizes 
B. subtilis and B. thuringiensis GDH (25.9 and 18.5 K, respectively) but destabilizes 
B. licheniformis GDH by 7.1 K.   The cause is verly likely electrostatic repulsion 
between E170K and wildtype K252, since it is known from the crystal structure that 
both residues interact with each other.  The mutation Q252L stabilized B. subtilis 
GDH by 17.3 K, while conversely, the mutation L252Q from wildtype B. 
  Position   
 155 170 252 ∆Tm(K)
[a]
 Half-life at 65
o
C(min) 
B. subtilis wt F E Q 0 <0.05
[b]
 
 Y E Q 1.2 <0.05
[c]
 
 F K Q 25.9 8.7 
 F E L 17.3 0.5 
 F K L 34.7 5323 
B. thuringiensis wt F E L 0 8.0 
 Y E L 4.5  
 F K L 18.5 3950 
 F E Q -19.3  
B. licheniformis wt F E K 0 8.7 
 Y E K 1.9  
 F K K -7.1  
 F E L 8.9 7.1 
 F E Q -2.7  
 F K L 5.6 4.2 
[a] CD: ellipticity at 222 nm (α-helix). The Tm of the wild-type GDH are 50.2
o
C 
for B. subtilis wt, 72.2
o
C for B. thuringiensis wt and 70.3
o
C for B. licheniformis 
wt.  [b] Half-life at 25
o
C ~22 min. [c] Half-life at 25
o
C ~176 min .  
 
 45 
thuringiensis GDH destabilized by 19.3 K.  In B. licheniformis GDH, the difference in 
Tm between Q252 and L252 was 11.6 K.  Furthermore, Baik et al. (6, 7) has found 
stabilization of the E170K and Q252L variants in B. megaterium GDH—83.5% 
identical to B. subtilis GDH—so the stabilizing effects of Y155 has been shown in 
three cases, and of K170 and L252 in four cases each.  Clearly, the positions 155, 170, 
and 252 are all important for stability, and residues in these positions apparently can 
be ordered with respect to stability as: 155: F < Y, 170: E < (K or R) (except in B. 
licheniformis, where K252 needs to be mutated to L to see a net improvement in 
stability, see above),  252: Q,K < L. 
3.4. Conclusions 
 In summary, we have demonstrated the stabilizing effect of consensus 
mutations in multiple natural and diverse variants of the same functionality.  
Additionally, we demonstrated that the structure-guided consensus concept is a very 
successful and widely applicable technique for generating thermostable proteins (86, 
120, 156)—further demonstrated in the improvement in the stability of GDH.   The 
stability of the His-tagged B. subtilis GDH was improved from ~20 minutes at 25oC 
to ~3.5 days at 65oC, a 106-fold improvement.  Using this approach we were able to 
identify residues critical to stability with considerably less effort than is involved in 
traditional directed molecular evolution (O(10) vs. O(104)—screening in the order of 
10 vs. 10,000).  The number of investigated variants can be tuned by the 
experimentalist; the two most influential factors are the amino acid identity range of 
the selected sequences and the chosen consensus level (here 50%).  In contrast to 
directed evolution, where key amino acids are first identified via high-throughput 
screening (HTS), each variation from the parent sequence has to be incorporated into 
the parent gene, and the variant purified and characterized.  In the case of difficult 
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and/or expensive substrates, not amenable to HTS, a small number of variants can be 
characterized directly on the substrate of interest, a strong advantage (“you get what 
you screen for”) (4).  The success of the structure-guided consensus concept depends 
on the diversity of available sequences.  The number of consensus candidates can then 
be reduced with available information, such as 1) stability data from thermostable or 
labile homologs, (47, 118) 2) crystallographic structures, including B-factor analysis 
(132) and Ramachandran plots, (50, 144) and 3) information about the deactivation 
mechanism, such as crucial subunit interactions, which might prefer surface residues.  
Often, use of all available data and tools optimizes output while minimizing effort.   
As discussed, if we had limited our search to the subunit-subunit interface, we would 
have increased our success rate from 46% to 86%.  The development of thermostable 
enzymes is of interest not only to the specialty chemical and pharma industries, but 
also to the protein engineer, since recent work has shown that evolvability is linked to 
stability (11, 13).  This finding supports the idea that protein engineering projects will 
benefit from starting with a stable protein scaffold.  Thus, straightforward, time-
saving techniques—such as the structure-guided consensus concept—are projected to 





CHARACTERIZATION OF GDH VARIANTS  
IN SALT SOLUTIONS AND  




 Enzymes are extraordinary catalysts that provide unsurpassed fidelity and 
selectivity under ambient and near ambient conditions of pH, temperature and solvent 
composition.  As target compounds in pharma become more complex and processes 
more environmentally demanding, biocatalysts are increasingly favored over non-
biological catalysts (29, 34, 104, 115, 122).  However, despite their indisputable 
favorable qualities, insufficient protein stability in reaction media has hampered 
biocatalyst implementation in organic synthesis.  Recognizing this shortcoming, a 
number of approaches have been developed to highly stable proteins for biocatalysis 
applications, either by isolating and expressing novel proteins with exceptional 
stability (52) or engineering the protein environment through the addition of co-
solutes (19, 33, 119), chemical modifications (119), and immobilization of the protein 
in solid or gel-like matrices (72, 119).  Alternatively, protein engineering methods 
have been used to modify the protein scaffold to improve hydrophobic interactions 
(82), electrostatic-surface interactions (157, 179), internal packing (41, 79), and 
increased rigidity (44, 96, 100) to withstand denaturing conditions.  Although 
comprehensive, generalizable guidelines for engineering stable proteins have not been 
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achieved, these innovative approaches have produced stable proteins with significant 
success (37, 38, 87) while also making significant contributions to our understanding 
of protein stability. 
 The stability of proteins in organic solvents is one particular problem that 
continuously receives attention due to increasing interest for industrial applications, in 
particular fine chemicals and pharmaceuticals.  Increased biocatalyst tolerance to 
organic solvents can allow for an increased concentration of denaturing substrates and 
products (e.g., alcohols and ketones for alcohol dehydrogenases and ketoreductases) 
to be used.  This in turn allows a wider range of operating conditions (i.e., reactant 
concentrations) to be utilized to optimize reactions by shifting reaction equilibrium, 
reduce/eliminate hydrolysis or polymerization side reactions, and avoid microbial 
contamination (36).  This results in increased productivity and thus more 
economically attractive processes.  Though much work has gone into understanding 
and predicting organic solvent effects on enzymatic activity based on water activity 
(165, 166), log P (83, 84), and solvent polarity (51, 77), most medium optimization 
for biocatalysis is done on a case by case basis.  Khemelnitsky et al. (76) have studied 
enzyme behavior in the combined presence of salts in organic solvents and progress 
has been summarized elsewhere (143).  In this work, salt and organic solvents effects 
on enzyme behavior will be studied independently. 
 Most interesting, it has been noted that an improvement in temperature 
stability results in a simultaneous increase in stability in the presence of organic 
solvents (and other denaturants) (31, 113).  Cowan et al. (31, 113) showed a positive 
correlation between thermal stability and tolerance to organic solvents and Hao et al., 
showed how a thermostable fructose biphosphate aldolase found via directed 
evolution also showed increased stability in organic solvents (54). 
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 In our previous work (see chapter 3) we improved the thermostability of a 
glucose 1-dehydrogenase (GDH) from Bacillus subtilis (B. subtilis) strain 168 via a 
structure-guided consensus concept (168).  This approach makes use of the consensus 
sequence (156) in addition to protein structure (or homology) to select and sieve 
through potential amino acid mutations.  GDH catalyzes the oxidation of glucose to 
gluconolactone with the concomitant reduction of NAD(P)+ to NAD(P)H.  GDH is an 
enzyme of great interest since it utilizes an abundant and inexpensive substrate, it 
accepts both NAD+ and NADP+, has very high activity (>100 U/mg), and is not 
thermodynamically limited due to the sponataneous hydrolysis of the gluconolactone.  
Currently, this enzyme is widely used (104, 121) and has great potential in the 
regeneration of nicotinamide cofactors for ketoreductions (34, 104), Baeyer-Villiger 
oxidations (102), alkane/alkene hydroxylation (178), carbon-carbon double bond 
reductions (27, 34, 53, 122) and amino acid dehydrogenases (16, 34).  In this work we 
characterize four variants of GDH from B. subtilis with different kinetic and 
thermodynamic stabilities in different stabilizing and destabilizing salts and a variety 
of organic cosolvents.  We intend to test the potential of the structure-guided 
consensus method toward developing enzymes tolerant to denaturing salts and organic 
cosolvents. 
4.2. Materials and Methods 
4.2.1. Cloning, site-directed mutagenesis via overlap extension and purification 
 GDH 6xHis-tagged variants were cloned, mutated and purified as described in 
section 3.2 (168).  Purified variants were then dialyzed in 50 mM phosphate pH 8.0 at 
4oC to remove imidazole and sodium chloride.  The concentration of the purified His-
tag GDH variants was measured via Bradford assay using commasie protein reagent 
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from Pierce (Rockford, IL).  For a representative SDS-PAGE of purified samples see 
Figure 3.2.   
4.2.2. Enzyme activity assay 
 Enzymes were assayed using a Beckmann-Coulter DU®800 
spectrophotometer (Fullerton, CA).  Enzyme was added to 1mL of assay solution 
containing 100 mM D-glucose, 1 mM NAD+ in 50 mM sodium phosphate pH 8.0.  
Enzyme activity was determined by monitoring NADH formation at 340 nm.  kd,obs 
was calculated from first-order deactivation kinetics.  
4.2.3. Hofmeister series, kinetic stability 
 Concentrated, pure His-tag GDH was diluted to 50 µg/mL with the different 
salts of interest (i.e., NaI, NaNO3, NaBr, NaCl, NaHCO2, NaF, NaSO4, and 
NaCH3CO2) in 50 mM sodium phosphate pH 8.0 at 0.95 and 0.99 water activity.  
Enzyme-salt mixtures were deactivated by incubating at 65oC and periodically 
assaying residual activity. 
4.2.4. NaCl, GDH temperature dependence 
 For varying NaCl concentrations, a concentrated stock solution of each GDH 
variant and a stock of 4 M NaCl in 50 mM phosphate pH 8.0 was mixed with 50 mM 
phosphate pH 8.0 to obtained the varying salt concentrations studied. 
4.2.5. Circular dichroism (CD) 
 CD ellipticity was measured with a Jasco J-810 (Easton, MD) with a Peltier-
controlled multi-cell holder using a quartz cuvette with a 1 mm path length.  Samples 
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were heated at approximately 3oC/min and change in CD ellipticity at 222 nm was 
monitored.  This data was then used to calculate apparent Tm. 
4.2.6. Kinetic stability at different temperatures: determination of T50
60
 
 Pure, dialyzed GDHs at 50 µg/mL were incubated at the different 
temperatures for one hour.  After incubation the residual activity was measured as 
described above (section 4.2.2.). 
4.2.7. Half-life in organic solvent 
 For half-life experiments, samples were prepared in 20% v/v organic solvent 
and incubated at 25oC.  Residual activity was measured until approximately 10% 
enzymatic activity remained.  Half-life was determined by first order deactivation 
kinetics. 
4.2.8. Kinetic stability in organic solvent: determination of C50
0
 
 A combination of: 1) concentrated NAD+ and D-glucose in pH 8.0 50 mM 
phosphate, 2) pH 8.0 50 mM phosphate, 3) organic solvent, and 4) pure, dialyzed 
enzyme were mixed to obtain different aqueous-organic cosolvent compositions.  
Mixture was assayed immediately upon enzyme addition. 
4.2.9. Kinetic stability in organic solvent: determination of C50
60
 
 Different proportions of 5 mM phosphate (to minimize buffer precipitation) 
and organic solvent by % v/v where made and precooled to 4oC.  Pure enzyme was 
then added to result in 50 µg/mL and the desired % v/v of organic solvent.  Samples 
were incubated for one hour at 4oC after which the residual activity was measured. 
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4.3. Results and Discussion 
 Four previously generated GDH variants (168) were selected to study salt and 
organic solvent effects on thermostable glucose dehydrogenases: tripe (P45A, F155Y, 
V227A), single (E170K), double (E170K, Q252L) and septet (P45A, N46E, F155Y, 
E170K, V227A, W230F, Q252L) variants, termed GDH1, GDH2, GDH3, and GDH4, 
respectively.  All GDHs studied contain an N-terminal His-tag to facilitate 
purification.  These variants were selected since they all had enhanced stability when 
compared to the wild-type, with half-lives of ~0.05, ~9.0 and ~5000 min at 65oC (300 
mM NaCl, 250 mM imidazole, 50 mM phosphate pH 8.0) for GDH1, GDH2, and 
GDH3/GDH4 (GDH3 and GDH4 have similar kinetic stability under these 
conditions).  The wild-type was not selected due to its low stability and thus difficulty 
to study at high temperatures in the presence of destabilizing salts or in organic 
cosolvents.  These variants, allowed the examination of a broad range of kinetic 
stability and to study their behavior in the presence of salts and organic cosolvents.  
4.3.1 Effects of salt type on glucose dehydrogenase kinetic stability 
 For characterization in salts we decided to test GDH in sodium salts along the 
Hofmeister series: I-, NO3-, Br-, Cl-, HCO2-, F-, SO42-, and CH3CO2- (Figure 4.1).  
Previous work demonstrated that enzyme deactivation in chaotropic solutions 
correlated exponentially with anion B-viscosity coefficients, a measure of ion 
Figure 4.1.  Hofmeister series. 
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hydration (76).  Moreover, an asymptotic stability is observed in the kosmotropic 
regime (19) which suggests a limiting stability obtainable in salt solutions.  Residual 
activities were measured at 65oC and the observable deactivation rate constant (kd,obs) 
calculated based on experimentally verified first-order deactivation kinetics.  The 
logarithm of the deactivation constant, log (kd,obs) was plotted against B-viscosity 
coefficients (Figure 4.2).  GDH1 was too unstable at 65oC to be appropriately 
characterized.  
 It is evident from the data that the GDH variants do not behave entirely as 
observed by Broering and Bommarius (19) with the characteristic negative linear 
correlation in the chaotropic regime with B-viscosity coefficient and constant log 
(kd,obs) in the kosmotropic regime.  Though both GDH3 and GDH4 appear to exhibit a 
lower bound for the value of kd,obs, consistent with prior observations(19), only the 
strongest chaotrope tested (NaI) significantly decreased protein stability.  In addition, 
GDH3 and GDH4 show a slight decrease in stability, up to a twofold increase in kd,obs 
(or a 10% difference in log (kd,obs) with increasing B-viscosity coefficient in the 
kosmotropic regime; this change might be within experimental error of the results 
observed previously (19). 
 The more thermostable variants (GDH3 and GDH4) demonstrate high stability 
regardless of salt-type at both water activities (aw) of 0.99 and 0.95.  Only NaI 
solutions demonstrate significant destabilizing effects at 0.95 water activity.  A 
decrease in kinetic stability with increasing chaotropic salt concentration has been 
previously observed (19).   
 The kinetic stability of GDH2 depended strongly on salt type.  The kd,obs value 
changed up to 500-fold between salts (I- versus Cl- at 0.95 water activity).  The same 
behavior—though smaller in magnitude is observed for GDH3 and GDH4.  From this 





Figure 4.2. Kinetic stability of GDH variants in different salts at aw=0.95 (solid markers) and 
aw=0.99 (open markers) at 65
oC and pH 8.0.  kd,obs values in 1/min.  A) GDH2 (E170K), B) 
GDH3 (E170K, Q252L), C) GDH4 (P45A, N46E, F155Y, E170K, V227A, W230F, Q252L).  
Inset values represent the B-viscosity coefficients with the corresponding anion in parenthesis. 
Fluoride was not tested at aw=0.95 since it is not soluble at this concentration. 
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 All GDH variants had increased stability at lower aw—increased salt 
concentrations—in all salts except in iodide.  In addition, this stability dependence on 
salt concentration is clearly observed for GDH2 and less pronounced for GDH3 and 
GDH4 with GDH3 showing more dependence in salt concentration than GDH4.  All 
in all, it is evident that those GDH variants with increased kinetic stability (GDH3 and 
GDH4) demonstrate less susceptibility to variations in stability based on salt types. 
4.3.2. Stability of glucose dehydrogenase as a function of salt concentration 
 For GDH, thermal stability has been previously improved by adding sodium 
chloride (6, 7, 107, 176).  The thermodynamic and kinetic stability of GDH1-GDH4 
was tested in solutions with NaCl concentrations ranging from 50 mM to 3 M. 
 To test thermodynamic stability, apparent melting temperatures (Tm) were 
recorded at 222 nm via circular dichroism.  All variants are stabilized with increasing 
NaCl concentration (Figure 4.3A).  Variants rank in the same order with respect to 
thermodynamic stability as previously in the case of kinetic stability: GDH4 > GDH3 
> GDH2 > GDH1.   
 If the influence of changing salt concentration on proteins fit a Debye-Hückel 
model, either log K or Tm, would yield a straight line when plotted against the square 
root of the ionic strength: log K/Ko or Tm/Tm,o = -A|zprotein· zsalt|(I)1/2 (62).  Tm values 
were normalized with respect to the most labile variant, GDH1 (P45A, F155Y, 
V227A): Tm,o~46.7oC (319.9K) without salt.  The ratios Tm/Tm,o were then plotted 
against the square root of the ionic strength of NaCl (Figure 4.3B).    Excellent linear 
behavior was observed for the three most stable variants (GDH2-4) with R2 > 0.99.  
The intercepts rank in order of thermal stability (from 1.00 for GDH1 to 1.11 for 
GDH4) while the slopes of the three most stable variants are the same within 
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measurement error.  Therefore, thermal stabilization of GDH does not occur via 
changes of the interaction of the protein surface with the surrounding medium but 
rather by enhancing cohesive forces in the interior of GDH. 
Figure 4.3. Thermodynamic stability of GDH variants in presence of NaCl.  A) 
Apparent melting temperature against NaCl concentration.  B)  Apparent melting 
temperature normalized to GDH1 at 0 M NaCl (319.9K) against the square root of 
the ionic strength.  Linear correlations for B: GDH4, y = 0.055x + 1.1057; GDH3, 




 The test of kinetic stability as a function of salt concentration reveals that 
GDH2 is strongly stabilized by salt concentrations up to 1 M (Figure 4.4).  While this 
trend has been observed earlier on wiltype GDH from B. megaterium (176), a close 
relative of the protein from B subtilis utilized here, although the exact functional 
relationship is different.  The strong salt dependency of GDH2 (E170K) matches 
finding by Baik et al. (6, 7).  The kinetic stability of GDH3 and GDH4 was virtually 
identical (168) (Figure 4.4), whereas the thermodynamic stability (as expressed by 
apparent Tm) of GDH4 was considerably higher than that for GDH3 (Figure 4.3).  As 
has been observed for deactivation of GDH upon changes in pH (7), kinetic stability 
is determined by dissociation of the obligate tetramer into subunits—for pH GDH 
dissociates into dimers (7).  In contrast, melting points as a basis for thermodynamic 
stability register unfolding events that apparently are more difficult to accomplish for 
GDH4 than for GDH3. 
Figure 4.4.  Kinetic stability of GDH variants in varying NaCl concentrations. 
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4.3.3. Organic solvent effects on glucose dehydrogenase 
 The stability of the GDH variants was studied in water-miscible organic 
solvent mixtures.  The use of monophasic solvent sytems allowed a wide range of 
aqueous-organic compositions to be considered and avoids deactivation effects due to 
interfacial denaturation at the aqueous-organic interphase (45, 113).  Other groups 
Figure 4.5.  A) T5060 for GDH variants.  GDH variants were incubated for 60 




have performed extensive studies of the effect of both miscible and immiscible 
organic solvents on enzymes (78, 97, 98, 141, 142).  Of interest was the ability to rank 
miscible solvents based on denaturation capacity (DC) (75) and the observed 
characteristic, sigmoid deactivation behavior (75, 106).  This sigmoidal drop-off in 
activity has also been observed in residual activity experiments to estimate T5060 
values—where values represent the temperature at which 50% activity (subscript) 
remains after 60 minutes incubation (superscript)—commonly used for quick 
screening of enzyme stability (6, 107, 132).  To start, T5060 values for GDH1-GDH4 
were determined (Figure 4.5A).  GDH demonstrated sigmoidal drop-off behavior and 
in addition, the T5060s increased with increasing apparent Tm (Figure 4.5B).  Then a 
range of six organic solvents were selected along the range of DCs (75): ethylene 
glycol, 1,2-propanediol, ethanol, acetonitrile, acetone, and 1,4-dioxane—arranged in 
increasing order of DC (Table 4.1).  Reactions containing increasing concentration of 
organic solvent in pH 8.0 phosphate buffer at 25oC were performed.  For all solvents 
except acetonitrile, the initial rate of GDH decreased with increasing organic solvent 
Table 4.1.  Half-lives (min) for GDHs at 25oC in 20% v/v organic solvent. 
Table 4.2.  C500[a] in %v/v for GDH variants. 
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concentration in a linear matter with consistent R2 values > 0.90 (see appendix, Figure 
A4.1), unlike the deactivation behavior reported by Khmelnitsky et al. (75).  For the 
case of acetonitrile, a minimum initial rate was observed around 40% volume (%v/v) 
for two GDH variants (see appendix, Figure S4.2).  Using the linear fits, C500s—the 
concentration of organic solvent by %v/v where 50% initial activity is retained—were 
determined for all solvents except acetonitrile (Table 4.2).  Although it is evident that 
the most labile variant (GDH1) has significantly lower stability (as determined by 
C500) in ethanol, acetone and 1,4-dioxane than the others, no particular trend is 
observed between variant thermostability (T5060), organic solvent type and C500s.  
Furthermore, the approach described by Khmelnitsky et al. (75) is unsuitable for GDH 
due to the low solubility of glucose, cofactor, and buffer at high organic cosolvent 
concentrations. 
 Half-lives where then determined in the presence of organic cosolvents.  The 
difficulty encountered was finding suitable conditions of temperature and organic 
solvent that would allow appropriate characterization of all variants—the half-lives of 
the selected variants differ by five orders of magnitude under previously studied 
conditions (300 mM NaCl, 250 mM imidazole, 50 mM phosphate pH 8.0) (168).  
GDH variant half-lives determined at 25oC in 20% v/v organic solvent are shown in 
Table 4.1.  Under these conditions no deactivation of the three more stable GDH 
variants was observed in ethylene glycol and 1,2-propanediol.  In the case of 1,4-
dioxane and acetonitrile the most labile variants denatured too quickly to measure 
half-lives effectively.  However, for ethanol, acetonitrile, acetone and 1,4-dioxane the 
more thermostable variants show increased stability (as demonstrated by longer half-
lives) at 20% v/v organic solvent. 
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 Next, to minimize any thermal deactivation, protein deactivation in the organic 
solvent was characterized at 4oC.  This temperature was selected to prevent the 
sample from freezing (some freezing was observed upon sample perturbation at > 
95% v/v for 1,4-dioxane which has a freezing point of 12oC (154)), and at this 
temperature no significant loss of activity was observed for all variants after 
incubating for one hour (Figure 4.5A).  GDH was added to increasing organic solvent 
concentrations, incubated for one hour at 4oC and the residual activity measured in 
aqueous buffer (pH 8.0, 50 mM sodium phosphate)—analogous to T5060.  The residual 
activity was then normalized with respect to the activity measured after one hour 
without organic solvent (Figure 4.6).  It is evident that a minimum in activity is 
observed around 50% v/v for all variants in all solvents studied.  This inverted bell-
shape has also been observed by Griebenow and Klibanov for subtilisin and lysozyme 
(48).  The authors studied α-helix content via FTIR in THF, 1-propanol, and 
acetonitrile.  They concluded that in aqueous-organic solvent mixtures two effects 
simultaneously act on protein stability: 1) the propensity of a protein to denature 
increases with the increase in organic solvent content, 2) as water content decreases, 
protein conformational mobility decreases and thus its ability to acquire the 
thermodynamically dictated conformation.  We surmise that, analogous to lysozyme 
and subtilisin (48), GDH has a higher propensity to denature in high organic solvent 
content but it is kinetically entrapped in a folded and thus active state.  For all GDH 
variants significant activity was observed after one hour incubation in > 80% v/v of 
organic solvent. 
 In the regime of low organic solvent content (< 50% v/v), all GDH variants 
seem to decrease in residual activity with increasing organic solvent content.  In this 
regime, C5060 data at 4oC (analogous to T5060)—the concentration in which 50% 
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activity remained (subscript) after 60 minute incubation (superscript)—were obtained 
(Table 4.3).  These C5060 values were then plotted against T5060 and apparent Tm values  
Figure 4.6.  Residual activity of GDH variants after 60 minute incubation at 4oC in 




(Figure 4.7).  A strong correlation between thermal stability and organic solvent 
stability exists, as noted by Cowan et al.(31, 113), with correlation coefficients (R2) > 
0.80 and > 0.95 between C5060 values and Tm and T5060, respectively.  To our 
knowledge, this work demonstrates for the first time that an enzyme variant 
constructed via a consensus-based approach resulted in improved organic solvent 
stability. 





 In summary, we have demonstrated that thermostable GDH variants 
constructed via the structure-guided consensus method(168) show increased stability 
in the presence of denaturing salts and organic cosolvents.  The two most 
temperature-stable variants, GDH3 and GDH4, also showed increased stability in the 
presence of I-, NO3-, and Br-—three chaotropic anions.  As previously observed, NaCl 
clearly stabilized GDH (6, 7, 107, 176), as demonstrated by increased Tm and kd,obs 
values.  However, even though NaCl increased the Tm (thermodynamic stability) of 
all variants by > 7oC and the Tm for GDH4 was higher than GDH3 (92.8oC vs 86.3oC, 
at 0.5 M NaCl), this did not translate to higher kd,obs (kinetic stability) in the presence 
of NaCl. 
 The most stable variant, GDH4 (P45A, N46E, F155Y, E170K, V227A, 
W230F, Q252L) showed a > 2500-fold increase in tolerance—as determined by half-
lives—to 20% v/v of acetone, acetonitrile and 1,4-dioxane at 25oC when compared to 
GDH1 (P45A, F155Y, V227A).  In addition, a 1.7-, 3.5-, and 5.7-fold improvement in 
C5060 values at 4oC were observed for ethanol, acetone and 1,4-dioxane for GDH4 
relative to GDH1. 
 It was shown that in the absence of NaCl, GDH4 is more stable kinetically 
(T5060) and thermodynamically than GDH3.  Under previous experimental conditions 
(300 mM NaCl, 250 mM imidazole, pH 8.0 50 mM sodium phosphate) this was not 
observed due to the presence of NaCl (168).  Consequently, the incorporation of five 
additional mutations (N45A, N46E, F155Y, V227A, and W230F) did in fact result in 




 While our results do not elucidate the factors governing GDH activity at high 
temperature, in salt solutions, or organic solvents, we believe the concept of 
corresponding states with respect to flexibility and stability is applicable(48, 49, 67, 
181).  It has been shown that enzyme conformational mobility is a key paramater 
allowing catalysis under given, distinct conditions.  Závodsky et al. (181) and 
Griebenow et al. (49) have demonstrated how enzyme function is maintained—at high 
temperatures and in the presence of organic solvents, respectively—as long as native-
like conformational mobility and stability is preserved.  Consequently, thermostable 
GDH4 is able to preserve its mobility and stability under denaturing conditions due to 
increased structural stability incurred previously via mutagenesis (168). 
 The existence of a correlation between temperature and organic solvent has 
been shown (31, 113), however this is the first time a consensus-based method has 
been demonstrated to improve stability in the presence of organic solvents and 
chaotropic salts.  The use of consensus sequences is one of many tools available for 
improving thermal stability of proteins (87) which here has been demonstrated to 
show promise in improving stability against other denaturants. 
    
  
 




RECOMMENDATIONS AND CONCLUSIONS 
 
5.1. Recommendations 
5.1.1 Improvement of high throughput screening assay for amines 
 A key requirement towards the development of a novel amine dehydrogenase 
is the use of a sensitive and selective assay.  In this work, we described and 
implemented a modified NAD+-dependent fluorescent assay towards amines based on 
work by Tsotsou et al. (163) (Figure 2.13).  In this assay a shift to alkaline pH resulted 
in a product the exact structure of which was unknown (4, 163).  After examining the 
literature (64, 90, 91), probable pathways are summarized in Figure 5.1.  At the 
instant of NaOH addition there are two competing reactions.  At dilute (0.1-1.0 N) 
NaOH concentrations the nicotinamide-ribose linkage of NAD+ (I) is broken, 
producing nicotinamide (III) and subsequently adenosine monophosphate (IV) via 
breakage of the pyrophosphate link (73).  This reaction has been shown not to be 
dependent on NaOH concentration (73).  In the presence of strong alkali (5 N NaOH) 
a strongly fluorescent product is generated without cleavage of the nicotinamide-
ribose linkage.  J. W. Huff (64) noticed that the unreactive N1-methylnicotinamide, 
when placed in an alkaline solution, produced the very reactive α-carbinol.  The α-
carbinol was found to condense with a variety of alcohols, ketones and aldehydes to 
yield highly fluorescent products—the ketones and aldehydes products being quite 
stable.  We believe that analogous to N1-methylnicotinamide—in the presence of 
NaOH—NAD+ goes through a carbinol intermediate (V) that upon reacting with an 
alcohol or ketone produces VI, which upon cyclization produces VII (64, 73).   
 Upon examining the possible pathways of NAD+ in the presence of NaOH, it 






























































































































































































































































































 Figure 5.1.  Probable pathways of the condensation reaction of NAD+. 
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result in increased variability and thus, loss of sensitivity.  During screening the 
LeuDH variants, (see Chapter 2) a mean background of 865.09 RFU was obtained.  
This was ~2x higher than previously obtained during our assay development. 
 To reduce background, a higher concentration of NaOH could be added.  This 
will help in shifting the produced NAD+ toward the desired fluorescent product.  
Furthermore, the addition of ketones, such as acetophenone (125) and acetone (64) 
result in the generation of stable fluorescent products with distinct excitation and 
emission maxima.  This mixture of fluorescent products can be optimized towards the 
generation of a predominant species.  The LeuDH screening assay was carried out in 
the presence of ~ 8 mM MIBK (substrate).  The saturation of our screening assay with 
MIBK (solubility of MIBK in water is ~170 mM (154)) should not only increase the 
probability of finding a hit by saturating the enzyme but also as consequence result in 
a predominant alkali fluorescent product with defined spectrofluorometic 
characteristics (Figure 5.2).     
5.1.2. Further protein engineering of LeuDH 
 Further protein engineering is required to an amine dehydrogenase of 
sufficient functionality+.  However, deciding which protein engineering tool to use 
from the many available (5) is not trivial.  Protein engineers use a variety of tools to 
adapt enzymes to novel substrates: error-prone PCR (23), DNA-shuffling (32), 
CASTing (129, 131), and site-directed mutagenesis, among others.  For selecting the 

















Figure 5.2.  Probable alkali fluorescent NAD+ product in presence of MIBK. 
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mechanism) as well as the availability of a high throughput screening or selection 
assay will ultimately dictate the most suitable approach.  If much is known on the 
enzyme of interest a rational approach can be taken.  In this case, an amino acid is 
chosen for site-directed mutagenesis, where one amino acid is replaced by another.  
This approach requires extensive protein knowledge.  A quasi-rational approach can 
be implemented where one or multiple amino acids are selected for focused 
randomization.  In this case, the selected amino acid/s is/are mutated to selected or all 
other amino acids.  Such an example of this technique is Combinatiorial Active-Site 
Saturation Test (CASTing) (129, 131, 132) or traditional site-saturated mutagenesis.  
These techniques have the advantage of a reduced library size while at the same time 
allows the search for non-obvious advantageous mutations. 
 Alternatively, directed molecular evolution can be used (5).  This technique 
requires little protein knowledge a priori.  With this approach, Darwinian evolution is 
carried out in a test tube.  The most popular method used for directed evolution is 
error-prone PCR (ep-PCR).  With this technique, as the name implies, the polymerase 
is stimulated to make mistakes by introduction of manganese ions and skewed 
deoxyribonucelotides concentrations during gene amplification via PCR.  The genes 
Figure 5.3.  Amino acids ≤ 5.5 Å from phenylpyruvate (shown in yellow) in the 
PheDH structure 1BW9 (167).  
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amplified via ep-PCR are prone to erroneous substitutions of nucleotides, resulting in 
amino acid substitutions during translation.  The advantage of this technique is that 
little protein knowledge is required for its implementation and that a larger sequence 
space can be investigated.  The drawback of this technique is that a robust, high 
throughput system is essential.  Ultimately, “you get what you screened for”(4). 
 It is evident from our results that further mutagenesis of LeuDH is necessary 
for obtaining an amine dehydrogenase of sufficient functionality.  Using X-ray crystal 
structures from PheDH and sequence alignments tools, a total of 22 amino acids in the 
vicinity (≤ 5.5 Å) of the substrate were identified (Figure 5.3; Table 5.1).  Using 
sequence alingment tools (59, 151, 152) the corresponding amino acids were 
determined in LeuDH and other amino acid dehydrogenases (AADHs) (Table 5.1).  
For sequences and hosts of AADHs used see Appendix, PRALINE alignment and 
consensus sequence for AADHs.  Lys68, Asp115, and Lys80 are implicated in the 
catalytic mechanism (8, 138, 140).  It is evident from Table 5.1 that Lys68, Asp115 
and Lys80 are conserved in all AADHs and this is not surprising since all amino acids 
are produced from the corresponding α-keto acid and Lys68 stabilizes the carboxyl 
group, Lys80 stabilizes the carbonyl group and Asp115 is believed to stabilize the 
imino intermediate (20, 167).    
 Studies by Baker et al (8) has identified five glycine residues (41, 42, 77, 78, 
and 290) that contribute to the shape of the LeuDH active site, three of which are in 
close proximity to the substrate.  Furthermore,  Sekimoto et al (139), mutated a 
tetrapeptide sequence (Gly-Gly-(Gly/Ala)-Lys80) upstream of Lys80.  They 
concluded that the conserved glycyl residues are important for fine-tuning the 
positioning of the ε-amino group of Lys80—Gly77 and Gly78 variants had markedly 
decreased thermal stabilities (139).  Leu40, Gly41, Ala113, Val291 and Val294 from 
LeuDH have been recognized via structural comparisons with GluDH to interact with 




 With this information we recommend that future protein engineering efforts 
focus on Leu40, Gly41, Gly42, Ala113, Glu114, Asp115, Val291 and Val294.  For 
convenience, these amino acids will be divided into three groups: Leu40-Gly42 (red 
or group A), Ala113-Asp115 (blue or group C), and Val291 and Val294 (cyan or 
group D) (Figure 5.4).  Mutagenesis of Leu40-Gly42 will help optimize the shape of 
Table 5.1.  Amino acids ≤ 5.5 Å from phenylpyruvate.  Column 1, amino acids in the 
vicinity of the substrate (PheDH structure 1BW9).  Column 2, corresponding amino 
acids in LeuDH from Bacillus sphaericus structure 1LEH.  Column 3, corresponding 
amino acid in LeuDH from (Geo)Bacillus stearothermophilus.  Column 4, recurring 
amino acids in LeuDHs.  Column 5, corresponding amino acids in amino acid 
dehydrogenases—a single entry means amino acid is conserved. 
1BW9 (PheDH from 
Rhodococcus sp. M4)





Ala38 Leu40 Leu40 Leu
LeuDH (Leu), PheDH (Leu), 
GluDH (K), AlaDH (Gly)
Gly39 Gly41 Gly41 Gly Gly
Gly40 Gly42 Gly42 Gly Gly
Met63 Met65 Met65 Met AlaDH (Ala), GluDH (Met, Gln)
Lys66 Lys68 Lys68 Lys AlaDH (Ile, Val, Arg)
Met67 Asn69 Asn69 Asn
PheDH (Cys), AlaDH (Cys, 
Ala), GluDH (Cys, Ala, Asn)
Met74 Leu76 Leu76 Leu
PheDH (Phe), GluDH (Tyr, 
Met, Ile)
Lys78 Lys80 Lys80 Lys AlaDH (Met, Leu)
Trp114 Ile111 Ile111 Ile, Tyr
PheDH (Tyr, Trp), GluDH (Ile, 
Val), AlaDH (Leu, Val)
Thr 115 Thr112 Thr112 Thr, Ile
PheDH (Thr), GluDH (Pro), 
AlaDH (Thr, Ala)
Gly116 Ala113 Ala113 Ala, Thr
PheDH (Gly), GluDH (Ala), 
AlaDH(Gln, Lys, Glu)
Pro117 Glu114 Glu114 Glu, Ala
PheDH (Thr, Pro), GluDH 
(Pro, Gly), AlaDH (Ala)
Asp118 Asp115 Asp115 Asp AlaDH (Ala, Leu)
Phe137 Thr134 Thr134 Thr
PheDH (Ala, Val, Asn, Phe), 
GluDH (Thr), AlaDH (Ala)
Ser149 Pro146 Pro146 Pro
PheDH (Ser, Thr), Glu (Arg), 
AlaDH (Glu)
Thr153 Val149 Ala149 Val, Ala
PheDH (Pro), GluDH (Ala, 
Thr), AlaDH (His, Lys, Gln)
Asn262 Asp261 Asn261 Asn AlaDH (Asp)
Asn288 Asn287 Asn287 Asn GluDH (Ser, His), AlaDH (His)
Gly291 Gly290 Gly290 Gly AlaDH (Ala, gly)
Ala292 Val291 Val291 Val
PheDH (Leu, Ala), AlaDH 
(Val, Ile) 
Leu295 Val294 Val294 Val
PheDH (Val, Leu), GluDH 
(Ser), AlaDH (Met)
Val296 Ala295 Ala295 Ala
PheDH (Ala, Val), GluDH (Tyr, 
Gly, Ala), AlaDH (Pro)
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the active site (Gly41 and Gly42) and enhance protein interactions with the aliphatic 
side-chain of L-leucine (Leu40) for improved binding of the substrate(8).  The 
mutagenesis of Ala113-Asp115 will allow for optimization of the protein interactions 
with the (unstable) imine intermediate and with a catalytic water molecule (20).  
Finally, mutagenesis of Val291 and Val294 will further improve binding by 
optimizing protein-substrate (substrate side-chain) interactions (8, 9, 18).  The 
selected amino acids, with bound phenylalanine are shown below (Figure 5.4). 
 For future mutagenesis we recommend CASTing, also known as iterative site-
saturation mutagenesis (ISM) (129-131).  This approach will allow us to mutate the 
selected amino acids by groups.  By focusing on these “hot sites”, the sequence space 
is significantly reduced.  A schematic representation of ISM is shown below (Figure 
5.5).  Various “routes” to improved activity can be used, but an exhaustive study is 
not necessary.  Mutagenesis of group B (green) has already been performed (see 
Chapter 2).  If mutagenesis is carried out using NNK (32 codons for 20 amino acids) 
degenerate codons at the remaining positions a total of at least 199,392 clones need to 
be screened, or > 2000, 96-well plates.  To reduce the library size NDT (12 codons for 
12 amino acids) or NNT (16 codons for 15 amino acids) degenerate primers should be 
Figure 5.4.  Selected amino acids for further mutagenesis.  Left, amino acid 
positions in PheDH and 1C1D active site with bound L-phenylalanine.  Right, 
amino acid positions in LeuDH and 1C1D active site without L-phenylalanine. 
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used.  This will reduce the library size by at least ~7.8x, resulting in 25,303 clones or 
~263, 96-well plates. 
5.1.3. Other scaffolds for engineering towards an amine dehydrogenase 
 The best enzyme candidates for engineering towards an amine dehydrogenase 
should have: known chemical mechanisms, available X-ray structures, high activity 
towards natural substrate, and slight activity towards desired substrate.  The most 
apparent alternate enzyme candidates would be other amino acid dehydrogenases.  
One of the most characterized is PheDH from Rhodococcus sp. M4 (20, 21, 167).  X-
ray crystal structures with substrates and analogs (167) and detailed chemical 
mechanism (167) are available and specific activities as high as 285 U/mg (for 
PheDH from Bacillus sphaericus) have been recorded (111).  Furthermore, PheDH is 
 
Figure 5.5.  Schematic representation of ISM.  The four sites selected are 
randomized in series.  The best variant from one group is selected for further 
mutagenesis at the different groups.  Adapted from Reetz 2007 (130). 
Figure 5.6.  In vivo reaction performed by DAPDH. From Vheda-Peters 2006(169). 
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known to accept a wide array of α-keto acids and amino acids (21, 111).  The 
similarity in chemical mechanism and protein structure with LeuDH would allow for 
a straightforward transition and application of acquired knowledge (e.g., beneficial 
mutations and screening assay) to PheDH. 
 Another interesting candidate for protein engineering is meso-2,6-
diaminopimelate dehydrogenase (DAPDH) (28, 135).  This enzyme has the unique 
trait of reductively aminating α-keto acids into the corresponding D-amino acids 
(Figure 5.6).  The enzyme complex with bound meso-aminopimelic acid and other 
analogs has been resolved (28, 135) (Figure 5.7).  As can be observed in Figure 5.7, 
this enzyme has very defined residues that stabilize the D and L amino acid groups in 
the substrate, meso-2,6-diaminopimelic acid.  Recently, Vedha-Peters et al. (169) 
where able to engineer the active site to accept a variety of substrates while retaining 
enantioselectivity.  The authors used a combination of rational design (mutagenesis of 
the L-amino acid-interacting residues) and directed evolution.  This enzyme has the 
potential of allowing a complete new set of chiral amines to be produced. 
 
Figure 5.7.  meso-DAP bound at the active site. L-amino center shown in yellow, D-
amino center shown in red.  Adapted from Cirilli 2000 (28). 
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5.1.4. Further stabilization of glucose 1-dehydrogenase: introduction of inter-
subunit disulfide bonds 
 GDH is an obligate tetramer and deactivation follows after loss in quaternary 
structure (subunit dissociation).  Upon increase in pH, GDH is known to dissociate 
into dimers resulting in enzyme inactivation (6, 7).  We believe temperature 
inactivation proceeds via the same route.  It was demonstrated by Baik et al. (7) that 
inactivation of the enzyme carrying either the E170K or Q252L mutations occurred 
via dissociation from a tetramer to a dimer without significant changes in the CD 
spectra.  This suggests that even though dissociation takes place, secondary structure 
is retained.  This is in agreement with our results from Chapter 3 and 4.  Five of the 
total 7 amino acids substitutions combined were at the interface, thus for improved 
stability the subunit-subunit interface needs to be reinforced (168).  Furthermore, it 
has been shown that in the presence of NaCl, GDH4 (P45A N46E F155Y E170K 
V227A W230F Q252L) has a high apparent melting temperature as demonstrated via 
CD but this did not translate to an increase in kinetic stability (determined via half-
life) when compared to other variants.  This suggests that the enzyme dissociates prior 
to unfolding, resulting in loss of catalytic activity. 
 Introduction of disulfide bonds at the subunit-subunit interface should improve 
kinetic stability by covalently linking the subunits together and preventing 
dissociation.  Disulfide bonds can make significant contributions to protein stability 
primarily by decreasing conformational chain entropy of the denatured protein (30, 
42, 114, 161, 173, 182).  The introduction of disulfide bonds for increased protein 
stability has successfully been applied to thermolysin-like proteases (95, 96), T4 
lysozyme (99), subtilisin E (158), ribonuclease H (71) and xylanase (170). 
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 First, amino acids at the subunit-subunit interface of GDH were determined.  
This was done using a program that integrates enhanced relative solvent accessibility 
(RSA) with high resolution data—SPPIDER (123).  SPPIDDER uses machine 
learning to combine protein interaction data, sequence-based data and structural 
features for enhanced recognition of protein-protein interaction sites (123).  RSA is 
defined as a ratio of the solvent exposed surface area (SA) of i-th amino acid residue 
in a given structure and some maximum value of exposed surface area (MSA) for the 





=      (5.1) 
Figure 5.8.  Schematic representation for determination of protein-protein interaction 
sites.  From Porollo 2007(123). 
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Porollo et al. (123) defined MSA as the exposed area obtained from an extended 
conformation of a tripeptide with the residue of interest as the central residue.  In the 
case of GDH, the program compares the relative solvent accessibility of all amino 
acids between a subunit in the tetramer (SA) and the free monomer (MSA).  A 
schematic representation of the procedure used to map interaction sites from multiple 
complexes is shown in Figure 5.8.  This program is available from 
Figure 5.9.  Interfacial amino acids of GDH.  Interfacial amino acids are shown in red 







Chain Residue numbers (Preserving PDB numeration) 
A 
69 101 102 104 106 109 110 113 114 117 118 121 122 125 129 132 148 149 151 153 
156 159 160 163 164 166 167 168 170 171 172 174 175 176 
B 
69 101 102 104 106 109 110 113 114 117 118 121 122 125 129 132 148 149 151 153 
156 159 160 163 164 166 167 168 170 171 172 174 175 176 
Chain Residue numbers (Preserving PDB numeration) 
A 
147 149 150 151 152 153 154 155 199 208 209 212 250 252 253 254 255 256 257 258 
259 260 261 
C 
147 149 150 151 152 153 154 155 199 208 209 212 250 252 253 254 255 256 257 258 
259 260 261 
 
Chain Residue numbers (Preserving PDB numeration) 
A 
1 2 26 170 174 177 178 180 182 214 215 217 219 223 226 227 230 235 237 238 239 
240 241 242 244 245 246 247 248 249 252 256 257 
D 
1 2 26 170 174 177 178 180 182 214 215 217 223 226 227 230 235 237 238 239 240 




http://sppider.cchmc.org/ (123, 124).  Using the tetramer structure of GDH from 
Bacillus megaterium IWG3 (180) and the solvent accessibility based protein-protein 
program (123, 124) residues at the interface were determined (Figure 5.9).  Bacillus 
megaterium IWG3 and Bacillus subtilis share 83.5% amino acid identity and are 
88.9% similar.  Equipped with the interfacial amino acids, the next step is identifying 
among this reduced set, potential pairs for disulphide bond formation. 
 SSBOND—a computer program—was used to identify potential sites for 
engineering a disulfide bond (55).  SSBOND is available from 
http://eagle.mmid.med.ualberta.ca/forms/ssbond.html (55).  This algorithm starts by 
generating Cβ positions from the N, Cα and C atom coordinates provided from a 
three-dimensional structure (for a schematic with the nomenclature of the dihedral 
angles in a disulfide bond see Appendix, Figure A5.1).  An initial screen selects 
residue pairs based on Cβ−Cβ distances.  For this limited set of pairs, Sγ positions are 
generated which satisfy a predefined (55) set of ideal values for all other bond lengths 
and bond angles.  Finally, the new conformations are subjected to energy 
minimization to remove large deviations from ideal geometry and their final energies 
and pairs are reported in the output. 
 GDH PDB files based on the crystal structure from Bacillus megaterium 
Figure 5.10.  Interfacial disulfide bond identified via SSBOND.  Chain A (blue), chain 
B (orange), chain C (red), chain D (green).  N terminal amino acids shown in spacefill 
and colored by chain.  P153C and E173C shown in spacefill and colored CPK. 
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IWG3 were created, with only interfacial amino acids.  One file was created for each 
protein interface: AB, AC, and AD.  These PDB structures were loaded into the 
program (SSBOND) and the output was screened for inter-subunit disulphide bonds.  
Only one pair was identified, Pro153-Glu175.  Mutagenesis of these two positions to 
cysteines would result in the creation of four disulphide bonds, two between chain A 
and B and two between chain D and C (Figure 5.10).  Unfortunately, no potential 
pairs were identified between the AD, AC, BC and BD interface.  The N-terminus, 
where the 6xHis-tag is located, lies in the AD and BC interface (Figure 5.10). 
 A Pro153Cys and Glu175Cys variant was constructed starting from GDH4.  
The final GDH variant had a total of nine mutations: P45A, N46E, P153C, F155Y, 
E170K, E175C, V227A, W230F, and Q252L.  The 6xHis-tag purified variant had a 
specific activity of ~ 0.7 U/mg and a half-life ~20 min at 65oC in elution buffer (300 
mM NaCl, 250 mM imidazole in 50 mM phosphate pH 8.0).  These experiments were 
carried out without oxidation of the disulfide bonds.  It is evident that these two 
mutations (P153C and E175C) destabilized the protein and reduced the activity 
(GDH4 has a specific activity ~120 U/mg and a half-life of ~3.5 days under the same 
conditions).  Sequence alignment shows that Pro153 is conserved in 9 out of 13 
GDHs aligned while Glu175 is conserved in all 13 (see Appendix, PRALINE 
alignment and consensus sequence).  Furthermore, Pro153 and Glu175 are located in 
a turn and α-helix, respectively.  Pro and Glu are known to stabilize these types of 
secondary structures (94).  Further studies without an N-terminal 6xHis-tag should be 
performed to test its influence on stability. 
5.1.5. Applications of the structure-guided consensus concept: cellulases 
 With prices of crude-oil rising, the need for alternative carbon sources for 
fuels and materials is evermore important.  Lignocellulosic matter as agricultural, 
industrial and forest residuals account for the majority of biomass in the world (81).  
Lignocellulosic material is primarily composed of 35-50% cellulose, 25-35% 
hemicellulose, 10-25% lignin, and pectins (81, 92).  The hydrolysis of these sugar 
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polymers for generating value-added products is a great challenge due to: the 
complexity of the enzymes necessary for hydrolysis, the lack of an organism that 
produces the necessary enzymes in sufficient quantities, the crystallinity and 
heterogeneity of the cellulose sources, and feedback product inhibition of the enzymes 
or repression of metabolic pathways (81, 92, 117).  In this discussion we will focus in 
the improvement of the enzymes required for hydrolysis—specifically cellulases. 
 Cellulases are divided into three major groups: endoglucanases, 
cellobiohydrolases (exoglucanases), and β-glucosidases (81).  An impediment 
hindering cellulases is the recalcitrance of cellulosic biomass.  This is primarily due to 
the crystallinity of the substrate, forming fibrils with such tight packing that makes it 
difficult for even water to penetrate (92).  As a result, various mechanical and 
chemical pretreatment methods have been developed for pretreatment prior to 
subsequent hydrolysis and fermentation (56, 66, 172).  However, the presence of 
residuals from the pretreatment often results in enzyme deactivation and inhibition.  
Thus, the development of robust, stable cellulases would allow for improved 
performance and increase in sugar yields, all vital to reducing costs (117). 
 Engineering cellulases is a difficult task due to the complexity of the enzyme, 
the dynamic enzyme-substrate interaction, the heterogeneous, insoluble substrate and 
the overall limited understanding of the system(126).  A general trait of most 
cellulases is a modular structure often including both catalytic and carbohydrate-
binding modules united by an interdomain linker (92, 126).  The binding module is 
involved in attachment of the cellulase to the cellulose surface bringing the catalytic 
domain in close proximity to the substrate (92).  The bi-functional linker is believed 
to provide spatial separation via a glycosilated, rigid part whereas a flexible, hinge-
like section allows autonomous domain function (126).   On the other hand, there are 
no definitive relationships between cellulase activities on soluble substrates and those 
on insoluble substrates.  Consequently, soluble substrates should not be used for 
screening improved cellulases (117). 
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 Although some successes have been reported (137), this lack of enzyme-
substrate understanding and its complexity makes rational design extremely difficult.  
Most work via rational design has focused on elucidating the chemical mechanism of 
the enzymes (126).  In contrast, directed molecular evolution allows for mutagenesis 
without a complete understanding of the enzyme structure or function.  However, the 
modular nature of the enzyme permits for much of the enzyme variants to be inactive 
and for much of the effort to be focused in undesired areas.  Furthermore, the 
insolubility of the substrate makes high-throughput screening difficult.  We believe 
that structure-guided consensus (120, 168) is a more attractive approach towards 
engineering stable cellulases.  This approach would allow for the binding, catalytic 
and linker domain to be optimized separately.  Furthermore, since this approach 
generates a reduced number of variants a more thorough enzyme-substrate 
characterization could be carried out. 
5.2. Conclusions 
 All in all, this work describes progress towards the development of a novel 
dehydrogenase for synthesis of chiral amines starting from a leucine dehydrogenase 
(Chapter 2).  Using site-saturated mutagenesis two key residues were mutated en 
route to enhanced binding and catalytic activity towards an unnatural substrate.  A 
NAD+-dependent fluorescent high throughput assay was optimized for screening.    
 Then, the traditional consensus method was modified by utilizing protein 
structural information and applied towards improving the overall stability of a glucose 
1-dehydrogenase.  This approach not only significantly enhanced thermal stability 
(Chapter 3) but also incurred stability towards other denaturants—specifically organic 
solvents and salt solutions (Chapter 5).     
 Future steps towards the development of an amine dehydrogenase should 
focus on those amino acids that surround the active site.  Other protein scaffolds to 
consider for the development of a novel amine dehydrogenase should be other amino 
acid dehydrogenases, in particular phenylalanine dehydrogenase, due to the wealth of 
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knowledge available.  Another candidate to consider is meso-2,6-diaminopimelate 
dehydrogenase.  This enzyme is of particular interest since it has been demonstrated 
to synthesize a wide array of D-amino acids, a chemistry not common in nature 
(nature is based on L-amino acids). 
 Further stabilization efforts on glucose 1-dehydrogenase should certainly 
focus at the subunit-subunit interface.  Our results suggest that this enzyme 
dissociates prior to unfolding, implying that further significant stabilization will be 
achieved by improving the interface and not by stabilizing intra-subunit interactions.  
An attempt, at further stabilizing glucose 1-dehydrogenase by insertion of inter-
subunit disulphide bonds resulted in loss of activity and stability.  Sequence 
alignments and inspection of secondary structure showed that these residues are 
highly conserved among glucose dehydrogenases and that mutagenesis at these 
positions to cysteines did not favor the present secondary structures. 
 Application of the structure-guided consensus method will prove useful to 
complex proteins whose substrates are not amenable to high throughput screening.  A 
good example would be cellulases.  The modular nature of cellulases and the 
crystallinity, low solubility and heterogeneity of their substrates makes this an ideal 
test case for the structure-guided consensus.  
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APPENDIX: Additional Figures 
 
Figure A2.1.  Representatibe SDS-PAGE of overexpression of LeuDH variants 
grown in 96-well plates with MagicMedia™.  Random wells were selected for testing 














































































































Figure A2.2.  Plot 2, screening of LeuDH variants. 
 












































































































Figure A2.3.  Plot 3, screening of LeuDH variants. 
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Figure A2.4.  Plot 4, screening of LeuDH variants. 
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Figure A3.1. Representative phylogenetic tree constructed by the neighboring joining method 



























































Table A3.1.  Legend of symbols for consensus alingment[a] 
Group Symbol Members 
Alcohol o S, T 
Aliphatic I I, L, V 
Any . A, C, D, E, F, G, H, I, K, L, M, N, P, 
Q, R, S, T, V, W, Y 
Aromatic a F, H, W, Y 
Charged c D, E, H, K, R 
Hydrophobic h A, C, F, G, H, I, K, L, M, R, T, V, W, 
Y 
Negative - D, E 
Polar p C, D, E, H, K, N, Q, R, S, T 
Positive + H, K, R 
Small s A, C, D, G, N, P, S, T, V 
Tiny u A, G, S 
Turnlike t A, C, D, E, G, H, K, N, Q, R, S, T 
















































Figure A3.2.  Amino acids selected for mutations in GDH.  A) GDH structure (white) 
with interfacial amino acids (blue). B) GDH structure with amino acids selected for 
substitutions (red). C) GDH structure with stabilizing mutations (green). D) Slab of 
GDH structure showing buried, surface and interfacial amino acids mutated. E) GDH 







Blue – interfacial amino acids
Red – Selected amino acids







Figure A4.1.  Representative linear behavior observed for initial activity experiments 
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